{
    "items": "194",
    "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
    "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
    "feed": [
        {
            "title": "Barron's Weekend Stock Picks: Uber Joins The S&P 500, Schwab Rebounds And What's Next for Johnson & Johnson? - Apple  ( NASDAQ:AAPL ) , Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/news/23/12/36059036/barrons-weekend-stock-picks-uber-joins-the-s-p-500-schwab-rebounds-and-whats-next-for-johnson-johnso",
            "time_published": "20231202T222929",
            "authors": [
                "Justin Chan"
            ],
            "summary": "Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. In \"Uber Joins the S&P 500.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/02/shutterstock_2256695601.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.304121,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.375251",
                    "ticker_sentiment_score": "0.227342",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PSX",
                    "relevance_score": "0.375251",
                    "ticker_sentiment_score": "0.418014",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "UBER",
                    "relevance_score": "0.375251",
                    "ticker_sentiment_score": "0.13721",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.375251",
                    "ticker_sentiment_score": "0.665314",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "KENVUE SHAREHOLDER ALERT: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Kenvue To Contact Him Directly To Discuss Their Options - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/12/g36057931/kenvue-shareholder-alert-faruqi-faruqi-securities-litigation-partner-james-josh-wilson-encourages-",
            "time_published": "20231202T141500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "If you suffered losses exceeding $100,000 investing in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus ( collectively, the \"Registration Statement\" ) issued in connection with the Company's May 2023 initial public offering ( the \"IPO\" or ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.744043"
                }
            ],
            "overall_sentiment_score": 0.129082,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.622414",
                    "ticker_sentiment_score": "-0.021961",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.093064",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Orthobiologics Market size to grow by USD 2.64 billion from 2022-2027, North America to account for 41% of market ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/orthobiologics-market-size-to-grow-by-usd-2-64-billion-from-2022-2027--north-america-to-account-for-41-of-market-growth---technavio-302002810.html",
            "time_published": "20231201T235500",
            "authors": [],
            "summary": "Orthobiologics Market size to grow by USD 2.64 billion from 2022-2027, North America to account for 41% of market ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.255235,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.101494",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OFIX",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.101494",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GMED",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.101494",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.101494",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.101494",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KIDS",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.101494",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANIK",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.101494",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CSBTF",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.101494",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.101494",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.101494",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IART",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.101494",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.101494",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BVS",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.101494",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Spinal Implants Market size to grow by USD 3.57 billion from 2023-2028, North America to account for 43% of market ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/spinal-implants-market-size-to-grow-by-usd-3-57-billion-from-2023-2028--north-america-to-account-for-43-of-market-growth---technavio-302002783.html",
            "time_published": "20231201T231500",
            "authors": [],
            "summary": "Spinal Implants Market size to grow by USD 3.57 billion from 2023-2028, North America to account for 43% of market ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.210048,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OFIX",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GMED",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MEDGF",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KIDS",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MCRPF",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Dow Jones Bucks Hawkish Powell As Yields Plunge; Tesla Falls On Huge 'Product Problem'",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-bucks-hawkish-powell-yields-plunge-tesla-falls/",
            "time_published": "20231201T213000",
            "authors": [
                "VIDYA RAMAKRISHNAN",
                "Investor's Business Daily"
            ],
            "summary": "Dow Jones Bucks Hawkish Powell As Yields Plunge. Tesla Falls On ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2022/06/Stock-jeromepowell2022-02-gov.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.997902"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.938238"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": -0.065192,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "PATH",
                    "relevance_score": "0.108712",
                    "ticker_sentiment_score": "0.093715",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.162437",
                    "ticker_sentiment_score": "-0.341492",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "AMBA",
                    "relevance_score": "0.108712",
                    "ticker_sentiment_score": "-0.134922",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.108712",
                    "ticker_sentiment_score": "0.019997",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.108712",
                    "ticker_sentiment_score": "0.019997",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IHG",
                    "relevance_score": "0.108712",
                    "ticker_sentiment_score": "-0.158523",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.054483",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "URI",
                    "relevance_score": "0.108712",
                    "ticker_sentiment_score": "-0.158523",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "GME",
                    "relevance_score": "0.108712",
                    "ticker_sentiment_score": "0.099193",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.108712",
                    "ticker_sentiment_score": "-0.140089",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IOT",
                    "relevance_score": "0.108712",
                    "ticker_sentiment_score": "-0.003346",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRVL",
                    "relevance_score": "0.108712",
                    "ticker_sentiment_score": "-0.095865",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Phacoemulsification Devices Market size to grow by USD 622.54 million from 2023-2028, North America to account for ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/phacoemulsification-devices-market-size-to-grow-by-usd-622-54-million-from-2023-2028--north-america-to-account-for-40-of-market-growth---technavio-302002779.html",
            "time_published": "20231201T194500",
            "authors": [],
            "summary": "Phacoemulsification Devices Market size to grow by USD 622.54 million from 2023-2028, North America to account for ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.274803,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HLMAF",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MTLZF",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STAA",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALC",
                    "relevance_score": "0.210579",
                    "ticker_sentiment_score": "0.203927",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GKOS",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HOCPF",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BHC",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TOPCF",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "JNJ: 3 Pharma Stocks Navigating Future Investments - Buy Now",
            "url": "https://stocknews.com/news/jnj-zts-wve-3-pharma-stocks-navigating-future-investments-buy-now/",
            "time_published": "20231201T190039",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "The surge in investment and spending in global medicine is fueling the pharma industry. Therefore, investors could consider investing in quality pharma stocks Zoetis Inc. ( ZTS ) , Wave Life Sciences Ltd. ( WVE ) , and Johnson & Johnson ( JNJ ) .",
            "banner_image": "https://stocknews.com/wp-content/uploads/2022/08/Kritika-Sarmah_Image-3.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999997"
                }
            ],
            "overall_sentiment_score": 0.220052,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ZTS",
                    "relevance_score": "0.348325",
                    "ticker_sentiment_score": "0.261057",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.032736",
                    "ticker_sentiment_score": "-0.042965",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.257328",
                    "ticker_sentiment_score": "0.074989",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WVE",
                    "relevance_score": "0.318485",
                    "ticker_sentiment_score": "0.142565",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Female Student-Athletes File Title IX Sex Discrimination Class Action Against University of Oregon",
            "url": "https://www.benzinga.com/pressreleases/23/12/n36050597/female-student-athletes-file-title-ix-sex-discrimination-class-action-against-university-of-oregon",
            "time_published": "20231201T185700",
            "authors": [
                "PRNewswire"
            ],
            "summary": "EUGENE, Ore, Dec. 1, 2023 /PRNewswire/ --Thirty-two female student-athletes filed a detailed sex discrimination class action over 100 pages long against the University of Oregon today for depriving women of equal treatment and benefits, equal athletic aid, and equal opportunities to participate ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": -0.043538,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "-0.065191",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Gets Analyst Upgrade Noting Bullish Pharma & MedTech Projections - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36045219/johnson-johnson-gets-analyst-upgrade-noting-bullish-pharma-medtech-projections",
            "time_published": "20231201T180510",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "UBS has upgraded Johnson & Johnson JNJ, citing a bullish view of the company's pharmaceutical business and expectations for MedTech growth that align with the market, which is mid-single-digit. This year, Johnson & Johnson spinoff its consumer health company Kenvue Inc KVUE to focus on healthcare ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/01/jnjioffice3.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.260478,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.616842",
                    "ticker_sentiment_score": "0.527447",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Texas Attorney General Alleges Pfizer Misled Public on COVID-19 Vaccine Efficacy - Pfizer  ( NYSE:PFE ) ",
            "url": "https://www.benzinga.com/general/biotech/23/12/36041571/texas-attorney-general-alleges-pfizer-misled-public-on-covid-19-vaccine-efficacy",
            "time_published": "20231201T155903",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Texas Attorney General Ken Paxton has filed a lawsuit against Pfizer Inc PFE, alleging the pharmaceutical giant misrepresented the efficacy of its widely-administered COVID-19 vaccine. Paxton argued that Pfizer's claim of 95% effectiveness was misleading, based on limited clinical trial data ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/01/pfe.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.064092,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.241684",
                    "ticker_sentiment_score": "-0.148844",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.83383",
                    "ticker_sentiment_score": "-0.25894",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.241684",
                    "ticker_sentiment_score": "-0.148844",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "S&P, Nasdaq slip as caution prevails ahead of Powell comments",
            "url": "https://www.reuters.com/markets/us/futures-muted-traders-gear-up-powells-remarks-2023-12-01/",
            "time_published": "20231201T151000",
            "authors": [
                "Amruta Khandekar",
                "Shristi A"
            ],
            "summary": "Traders work on the floor at the New York Stock Exchange ( NYSE ) in New York City, U.S., October 27, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",
            "banner_image": "https://graphics.reuters.com/BRV-BRV/lbvgoakravq/chart.png",
            "source": "Reuters",
            "category_within_source": "Markets",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": -0.108587,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BABA",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.008131",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "-0.091462",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ULTA",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "-0.081395",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PARA",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.008131",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.099518",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "-0.099521",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "0.099518",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRVL",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "-0.189325",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "The Ad Council's 69th Annual Public Service Award Dinner Celebrates Extraordinary Progress of Social Impact Efforts and Inspires the Media and Marketing Industries to Come Together for Tomorrow",
            "url": "https://www.prnewswire.com/news-releases/the-ad-councils-69th-annual-public-service-award-dinner-celebrates-extraordinary-progress-of-social-impact-efforts-and-inspires-the-media-and-marketing-industries-to-come-together-for-tomorrow-302003333.html",
            "time_published": "20231201T143200",
            "authors": [
                "The Ad Council"
            ],
            "summary": "The Ad Council's 69th Annual Public Service Award Dinner Celebrates Extraordinary Progress of Social Impact Efforts ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/748305/Ad_Council_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.330969,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.022181",
                    "ticker_sentiment_score": "0.104054",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PYPL",
                    "relevance_score": "0.022181",
                    "ticker_sentiment_score": "0.104054",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.066475",
                    "ticker_sentiment_score": "0.125278",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.022181",
                    "ticker_sentiment_score": "0.165316",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "IHRT",
                    "relevance_score": "0.044345",
                    "ticker_sentiment_score": "0.114025",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.022181",
                    "ticker_sentiment_score": "0.104054",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.132489",
                    "ticker_sentiment_score": "0.211174",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.022181",
                    "ticker_sentiment_score": "0.104054",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCZ",
                    "relevance_score": "0.022181",
                    "ticker_sentiment_score": "0.104054",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DEO",
                    "relevance_score": "0.022181",
                    "ticker_sentiment_score": "0.104054",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Ad Council's 69th Annual Public Service Award Dinner Celebrates Extraordinary Progress of Social Impact Efforts and Inspires the Media and Marketing Industries to Come Together for Tomorrow",
            "url": "https://www.benzinga.com/pressreleases/23/12/n36044063/the-ad-councils-69th-annual-public-service-award-dinner-celebrates-extraordinary-progress-of-socia",
            "time_published": "20231201T143200",
            "authors": [
                "PRNewswire"
            ],
            "summary": "NEW YORK, Dec. 1, 2023 /PRNewswire/ -- On Thursday, November 30, the Ad Council, America's leading organization harnessing the power of communications for social change, held its Annual Public Service Award Dinner.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.324379,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.02214",
                    "ticker_sentiment_score": "0.104028",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PYPL",
                    "relevance_score": "0.02214",
                    "ticker_sentiment_score": "0.104028",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.066352",
                    "ticker_sentiment_score": "0.125269",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.02214",
                    "ticker_sentiment_score": "0.16528",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "IHRT",
                    "relevance_score": "0.044263",
                    "ticker_sentiment_score": "0.114004",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.02214",
                    "ticker_sentiment_score": "0.104028",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.110361",
                    "ticker_sentiment_score": "0.189622",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.02214",
                    "ticker_sentiment_score": "0.104028",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCZ",
                    "relevance_score": "0.02214",
                    "ticker_sentiment_score": "0.104028",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DEO",
                    "relevance_score": "0.02214",
                    "ticker_sentiment_score": "0.104028",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors - Akari Therapeutics  ( NASDAQ:AKTX ) ",
            "url": "https://www.benzinga.com/pressreleases/23/12/g36041855/akari-therapeutics-appoints-experienced-life-sciences-entrepreneur-samir-r-patel-m-d-to-board-of-d",
            "time_published": "20231201T130000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "NEW YORK and BOSTON, Dec. 01, 2023 ( GLOBE NEWSWIRE ) -- Akari Therapeutics, Plc AKTX, a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the appointment of experienced life sciences entrepreneur Samir R.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                }
            ],
            "overall_sentiment_score": 0.072779,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AKTX",
                    "relevance_score": "0.155702",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.078226",
                    "ticker_sentiment_score": "0.034409",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Warren Buffett Reduced This Long-Time Berkshire Hathaway Holding by 67%. Should Investors Follow His Lead?",
            "url": "https://www.fool.com/investing/2023/12/01/warren-buffett-reduced-this-long-time-berkshire-ha/",
            "time_published": "20231201T121000",
            "authors": [
                "Courtney Carlsen"
            ],
            "summary": "Berkshire Hathaway trimmed several longtime holdings in the third quarter, including this stock it has held since 2001.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F756464%2Fbuffett19-tmf.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.986714"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.195782,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AON",
                    "relevance_score": "0.054607",
                    "ticker_sentiment_score": "-0.027893",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.054607",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GL",
                    "relevance_score": "0.626755",
                    "ticker_sentiment_score": "0.279326",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.054607",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.318897",
                    "ticker_sentiment_score": "0.077284",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.054607",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.054607",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UPS",
                    "relevance_score": "0.054607",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MKL",
                    "relevance_score": "0.054607",
                    "ticker_sentiment_score": "-0.027893",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Tencent-Backed AI Drug Discovery Startup Xtalpi Files For Hong Kong IPO",
            "url": "https://www.forbes.com/sites/zinnialee/2023/12/01/tencent-backed-ai-drug-discovery-startup-xtalpi-files-for-hong-kong-ipo/",
            "time_published": "20231201T100507",
            "authors": [
                "Zinnia Lee"
            ],
            "summary": "Xtalpi, a Shenzhen-based company which uses artificial intelligence to find chemical compounds that could be developed into new drugs, has filed for an initial public offering in Hong Kong. Xtalpi did not disclose details of its IPO in its filing to the Hong Kong stock exchange on Thursday ...",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/6569ad0c82cf45e28c084682/0x0.jpg?format=jpg&crop=3000,1688,x0,y224,safe&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.135794,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.074692",
                    "ticker_sentiment_score": "0.030329",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CKHUF",
                    "relevance_score": "0.074692",
                    "ticker_sentiment_score": "-0.00707",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.074692",
                    "ticker_sentiment_score": "0.13128",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.074692",
                    "ticker_sentiment_score": "-0.00707",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SZIHF",
                    "relevance_score": "0.074692",
                    "ticker_sentiment_score": "0.100929",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.074692",
                    "ticker_sentiment_score": "-0.00707",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SBMFF",
                    "relevance_score": "0.148731",
                    "ticker_sentiment_score": "0.014007",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TCTZF",
                    "relevance_score": "0.074692",
                    "ticker_sentiment_score": "0.030329",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Contact Lens Market Size & Share to Surpass USD 12.6 billion by 2031 | Analysis by Transparency Market Research Inc.",
            "url": "https://www.benzinga.com/pressreleases/23/12/g36038372/contact-lens-market-size-share-to-surpass-usd-12-6-billion-by-2031-analysis-by-transparency-market",
            "time_published": "20231201T080824",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Dec. 01, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. -The global contact lens market was estimated to have acquired US$ 7.9 billion in 2022. It is anticipated to register a 5.5% CAGR from 2023 to 2031 and by 2031.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.362459,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.132611",
                    "ticker_sentiment_score": "0.310652",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Cosmetic skin care market size to grow by USD 79.37 billion from 2022 to 2027 | Amorepacific Group Inc., Beiersdorf ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/cosmetic-skin-care-market-size-to-grow-by-usd-79-37-billion-from-2022-to-2027--amorepacific-group-inc-beiersdorf-ag-chanel-ltd-and-more-among-the-key-companies-in-the-market---technavio-302002398.html",
            "time_published": "20231201T021500",
            "authors": [],
            "summary": "Cosmetic skin care market size to grow by USD 79.37 billion from 2022 to 2027 | Amorepacific Group Inc., Beiersdorf ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.371916,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PRBZF",
                    "relevance_score": "0.125789",
                    "ticker_sentiment_score": "0.34142",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BDRFF",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.04901",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KAOCF",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.04901",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSDOF",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.04901",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REVRQ",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.04901",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.04901",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.04901",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UL",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.04901",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CL",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.04901",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.04901",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Jim Cramer explains why it's hard to be bullish on the healthcare sector",
            "url": "https://www.cnbc.com/2023/11/30/jim-cramer-explains-why-its-hard-to-be-bullish-on-healthcare.html",
            "time_published": "20231201T013224",
            "authors": [
                "Julie Coleman"
            ],
            "summary": "CNBC's Jim Cramer on Thursday detailed what may be hurting healthcare stocks.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107341660-1701390277MM-F-113023-short.jpg?v=1701390276&w=750&h=422&vtcrop=y",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.019756,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HUM",
                    "relevance_score": "0.178459",
                    "ticker_sentiment_score": "0.024865",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.089797",
                    "ticker_sentiment_score": "-0.093835",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.089797",
                    "ticker_sentiment_score": "-0.054268",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.089797",
                    "ticker_sentiment_score": "-0.120177",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Texas AG Sues Pfizer Over Covid Vaccine Effectiveness",
            "url": "https://www.forbes.com/sites/mollybohannon/2023/11/30/texas-ag-sues-pfizer-over-covid-vaccine-effectiveness/",
            "time_published": "20231130T223933",
            "authors": [
                "Molly Bohannon"
            ],
            "summary": "Texas Attorney General Ken Paxton announced Thursday he sued pharmaceutical company Pfizer for misleading Texans about the efficacy of its Covid-19 vaccine and \"attempting to censor public discussion\"-despite the vaccine continuing to be effective and recommended by leading health agencies.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65690ead4f3849c2aa0fda5e/0x0.jpg?format=jpg&crop=4000,2252,x0,y206,safe&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.070317,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.130217",
                    "ticker_sentiment_score": "0.054082",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.488007",
                    "ticker_sentiment_score": "-0.092263",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.130217",
                    "ticker_sentiment_score": "0.054082",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc.  ( KVUE )  - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/11/g36030004/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains",
            "time_published": "20231130T181857",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LOS ANGELES, Nov. 30, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( \"GPM\" ) reminds investors of the upcoming December 8, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Kenvue Inc. ( \"Kenvue\" or the ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.021733,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.612343",
                    "ticker_sentiment_score": "0.039842",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.062597",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.062597",
                    "ticker_sentiment_score": "0.086023",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Turkey launches investigation into 19 pharma companies",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/turkey-launches-investigation-into-19-pharma-companies-2023-11-30/",
            "time_published": "20231130T161900",
            "authors": [
                "Reuters"
            ],
            "summary": "ANKARA, Nov 30 ( Reuters ) - Turkey's competition authority said on Thursday it had launched an investigation into 19 pharmaceutical companies to determine whether they had violated competition law.",
            "banner_image": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.webp?d=165",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.061418,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "PCRFF",
                    "relevance_score": "0.211191",
                    "ticker_sentiment_score": "-0.075673",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.211191",
                    "ticker_sentiment_score": "-0.075673",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.407844",
                    "ticker_sentiment_score": "0.063531",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.407844",
                    "ticker_sentiment_score": "-0.090206",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.407844",
                    "ticker_sentiment_score": "-0.090206",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.407844",
                    "ticker_sentiment_score": "-0.041052",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "When it Comes to Treating Ulcerative Colitis, US Gastroenterologists May be Betting it All on JAK…",
            "url": "https://www.benzinga.com/pressreleases/23/11/g36026546/when-it-comes-to-treating-ulcerative-colitis-us-gastroenterologists-may-be-betting-it-all-on-jak",
            "time_published": "20231130T155935",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Exton, Pennsylvania, Nov. 30, 2023 ( GLOBE NEWSWIRE ) -- With the Ulcerative Colitis ( UC ) market set to heat up in the coming months, the JAK class seems poised to become a dominant treatment, challenging established alternative mechanism of action ( AMOA ) favorites: Takeda's Entyvio ( ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.226782,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.036587",
                    "ticker_sentiment_score": "0.139865",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Ascends While Market Falls: Some Facts to Note",
            "url": "https://www.zacks.com/stock/news/2191136/johnson-johnson-jnj-ascends-while-market-falls-some-facts-to-note",
            "time_published": "20231129T224508",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $152.11, denoting a +0.32% change from the preceding trading day.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default295.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.961735"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.215358,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.511734",
                    "ticker_sentiment_score": "0.202836",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Occupational Medicines Global Market Report 2023 Highlights Robust Growth: Market Size To Reach $6.2 Billion By 2027 As Per The Business Research Company's Occupational Medicines Global Market Report 2023",
            "url": "https://www.benzinga.com/pressreleases/23/11/g36005663/occupational-medicines-global-market-report-2023-highlights-robust-growth-market-size-to-reach-6-2",
            "time_published": "20231129T163000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Nov. 29, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Occupational Medicines Global Market Report 2023, the global occupational medicines market is poised for significant expansion, projecting a rise from $4.52 billion in 2022 to $4.86 billion in 2023, demonstrating ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.289086,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PFE",
                    "relevance_score": "0.064623",
                    "ticker_sentiment_score": "0.242625",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.064623",
                    "ticker_sentiment_score": "0.242625",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Is a Trending Stock: Facts to Know Before Betting on It",
            "url": "https://www.zacks.com/stock/news/2190784/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it",
            "time_published": "20231129T140010",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default29.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.503496"
                }
            ],
            "overall_sentiment_score": 0.244283,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.47147",
                    "ticker_sentiment_score": "0.138208",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Largest Holding in Warren Buffett's \"Secret\" Portfolio Has Been a Guaranteed Moneymaker  ( With 1 Big Condition ) ",
            "url": "https://www.fool.com/investing/2023/11/29/warren-buffett-secret-portfolio-certain-moneymaker/",
            "time_published": "20231129T100600",
            "authors": [
                "Sean Williams"
            ],
            "summary": "This security has a flawless track record of making investors with a long-term mindset richer.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F756098%2Fbuffett8-tmf.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999954"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.212589,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SIRI",
                    "relevance_score": "0.101012",
                    "ticker_sentiment_score": "0.011053",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.033751",
                    "ticker_sentiment_score": "0.040337",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.033751",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.134402",
                    "ticker_sentiment_score": "0.167499",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.033751",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.033751",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®",
            "url": "https://www.globenewswire.com/news-release/2023/11/29/2787527/0/en/Alvotech-Announces-Positive-Top-Line-Results-from-a-Pharmacokinetic-Study-for-AVT05-a-Proposed-Biosimilar-for-Simponi-and-Simponi-Aria.html",
            "time_published": "20231129T090000",
            "authors": [
                "Alvotech"
            ],
            "summary": "The study, assessing pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi® ( golimumab ) in healthy adult subjects, met its primary endpoint The study, assessing pharmacokinetics, safety, and tolerability of AVT05 compared to Simponi® ( golimumab ) in healthy adult subjects, ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                }
            ],
            "overall_sentiment_score": 0.149298,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ALVO",
                    "relevance_score": "0.5443",
                    "ticker_sentiment_score": "0.195549",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.025873",
                    "ticker_sentiment_score": "0.059406",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMDA",
                    "relevance_score": "0.025873",
                    "ticker_sentiment_score": "0.059406",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LTUS",
                    "relevance_score": "0.025873",
                    "ticker_sentiment_score": "0.059406",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.025873",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®",
            "url": "https://www.globenewswire.com/news-release/2023/11/29/2787524/0/en/Alvotech-Announces-Positive-Top-Line-Results-from-a-Pharmacokinetic-Study-for-AVT05-a-Proposed-Biosimilar-for-Simponi-and-Simponi-Aria.html",
            "time_published": "20231129T090000",
            "authors": [
                "Alvotech"
            ],
            "summary": "Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive top-line results from a pharmacokinetic study for AVT05, a biosimilar candidate to Simponi® and Simponi Aria® ( golimumab ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                }
            ],
            "overall_sentiment_score": 0.156296,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ALVO",
                    "relevance_score": "0.539466",
                    "ticker_sentiment_score": "0.194606",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.025596",
                    "ticker_sentiment_score": "0.059312",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMDA",
                    "relevance_score": "0.025596",
                    "ticker_sentiment_score": "0.059312",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LTUS",
                    "relevance_score": "0.025596",
                    "ticker_sentiment_score": "0.059312",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.025596",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Final Deadline Approaching for Kenvue Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Kenvue Inc.  ( KVUE )  Investors of December 8, 2023 Lead Plaintiff Deadline - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35990408/final-deadline-approaching-for-kenvue-inc-investors-kessler-topaz-meltzer-check-llp-reminds-kenvue",
            "time_published": "20231128T213200",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "RADNOR, Pa., Nov. 28, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Kenvue Inc. ( \"Kenvue\" ) KVUE. ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": 0.096899,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.526003",
                    "ticker_sentiment_score": "-0.013368",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.129961",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update",
            "url": "https://www.globenewswire.com/news-release/2023/11/28/2787373/0/en/Alvotech-Reports-Financial-Results-for-First-Nine-Months-of-2023-and-Provides-Business-Update.html",
            "time_published": "20231128T211500",
            "authors": [
                "Alvotech"
            ],
            "summary": "Alvotech ( NASDAQ: ALVO, or the \"Company\" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported unaudited financial results for the first nine months of 2023 and provided a summary of recent corporate ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.989041"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.166184,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LTUS",
                    "relevance_score": "0.013732",
                    "ticker_sentiment_score": "0.054728",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.02746",
                    "ticker_sentiment_score": "0.125229",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALVO",
                    "relevance_score": "0.418212",
                    "ticker_sentiment_score": "0.230367",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.013732",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.013732",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.013732",
                    "ticker_sentiment_score": "0.054728",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMDA",
                    "relevance_score": "0.013732",
                    "ticker_sentiment_score": "0.054728",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:ISK",
                    "relevance_score": "0.02746",
                    "ticker_sentiment_score": "0.148748",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:SEK",
                    "relevance_score": "0.02746",
                    "ticker_sentiment_score": "0.148748",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.02746",
                    "ticker_sentiment_score": "0.193636",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update",
            "url": "https://www.globenewswire.com/news-release/2023/11/28/2787372/0/en/Alvotech-Reports-Financial-Results-for-First-Nine-Months-of-2023-and-Provides-a-Business-Update.html",
            "time_published": "20231128T211500",
            "authors": [
                "Alvotech"
            ],
            "summary": "REYKJAVIK, Iceland, Nov. 28, 2023 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO, or the \"Company\" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported unaudited financial results for the first nine months of ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.989041"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.16388,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LTUS",
                    "relevance_score": "0.013685",
                    "ticker_sentiment_score": "0.054708",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.027366",
                    "ticker_sentiment_score": "0.125172",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALVO",
                    "relevance_score": "0.416916",
                    "ticker_sentiment_score": "0.229878",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.013685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.013685",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.013685",
                    "ticker_sentiment_score": "0.054708",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMDA",
                    "relevance_score": "0.013685",
                    "ticker_sentiment_score": "0.054708",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:ISK",
                    "relevance_score": "0.027366",
                    "ticker_sentiment_score": "0.148694",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:SEK",
                    "relevance_score": "0.027366",
                    "ticker_sentiment_score": "0.148694",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.027366",
                    "ticker_sentiment_score": "0.193576",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "5 Best Blue-Chip Stocks For 2024",
            "url": "https://www.forbes.com/sites/investor-hub/article/best-blue-chip-stocks/",
            "time_published": "20231128T210308",
            "authors": [
                "CFP(R)",
                "Jason Kirsch"
            ],
            "summary": "Blue chip stocks have long been popular for investors of all wealth and ages. This article will explain blue-chip stocks and list five top picks for the upcoming year. Blue chip stocks refer to shares of well-established, financially robust companies with a long history of stable earnings, a ...",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/656631933fbf53922a25312f/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.998962"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.955357"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.50643,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.099642",
                    "ticker_sentiment_score": "0.252801",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.059885",
                    "ticker_sentiment_score": "0.198102",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.079788",
                    "ticker_sentiment_score": "0.294124",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.059885",
                    "ticker_sentiment_score": "0.251497",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "US FDA investigating safety risk of CAR-T cancer therapies",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-investigating-safety-risk-car-t-cancer-therapies-2023-11-28/",
            "time_published": "20231128T184200",
            "authors": [
                "Pratik Jain"
            ],
            "summary": "Signage is seen outside of the Food and Drug Administration ( FDA ) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights Nov 28 ( Reuters ) - The U.S.",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/RAQCGVLRB5NEBN7F7E43VWZSTE.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": -0.108946,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AUTL",
                    "relevance_score": "0.113062",
                    "ticker_sentiment_score": "-0.032092",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSVT",
                    "relevance_score": "0.113062",
                    "ticker_sentiment_score": "-0.077521",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.113062",
                    "ticker_sentiment_score": "-0.247011",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.113062",
                    "ticker_sentiment_score": "-0.247011",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Shein, Skims, Starlink: Billionaire-Linked Brands Could Go Public In 2024",
            "url": "https://www.forbes.com/sites/dereksaul/2023/11/28/shein-skims-starlink-billionaire-linked-brands-could-go-public-in-2024/",
            "time_published": "20231128T155454",
            "authors": [
                "Derek Saul"
            ],
            "summary": "Shein, the Chinese fast fashion behemoth, reportedly filed confidential paperwork Monday to go public in the U.S., setting the clothing company up to potentially headline a deep roster of high-profile upcoming initial public offerings.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65660c6c9d4a748f322ca68d/0x0.jpg?format=jpg&crop=2497,1403,x0,y0,safe&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.117223,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.082677",
                    "ticker_sentiment_score": "0.04532",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIRK",
                    "relevance_score": "0.082677",
                    "ticker_sentiment_score": "0.04532",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.082677",
                    "ticker_sentiment_score": "0.04532",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Executives From Leading Retail and Healthcare Companies Join GS1 US Board of Governors - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/executives-from-leading-retail-and-healthcare-companies-join-gs1-us-board-of-governors-301999185.html",
            "time_published": "20231128T141500",
            "authors": [],
            "summary": "Executives From Leading Retail and Healthcare Companies Join GS1 US Board of Governors PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.303532,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.051999",
                    "ticker_sentiment_score": "0.122523",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PVH",
                    "relevance_score": "0.051999",
                    "ticker_sentiment_score": "0.122523",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.051999",
                    "ticker_sentiment_score": "0.122523",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EBAY",
                    "relevance_score": "0.051999",
                    "ticker_sentiment_score": "0.122523",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.103778",
                    "ticker_sentiment_score": "0.031633",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.051999",
                    "ticker_sentiment_score": "0.122523",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.051999",
                    "ticker_sentiment_score": "0.122523",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.051999",
                    "ticker_sentiment_score": "0.122523",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Is Warren Buffett Selling Amazon Stock Instead of Buying It Hand Over Fist?",
            "url": "https://www.fool.com/investing/2023/11/28/why-is-warren-buffett-selling-amazon-stock-instead/",
            "time_published": "20231128T105000",
            "authors": [
                "Keith Speights"
            ],
            "summary": "The Oracle of Omaha isn't fully on the Amazon bandwagon for one likely reason.",
            "banner_image": "https://g.foolcdn.com/editorial/images/756187/buffett2-tmf.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.658903"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.178756,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.064104",
                    "ticker_sentiment_score": "0.061504",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.064104",
                    "ticker_sentiment_score": "0.061504",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.801858",
                    "ticker_sentiment_score": "0.286686",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.190667",
                    "ticker_sentiment_score": "0.073065",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.064104",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.064104",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Unstoppable Dividend Stocks Trading Near 52-Week Lows to Buy Now",
            "url": "https://www.fool.com/investing/2023/11/28/2-top-dividend-stocks-trading-near-52-week-lows-to/",
            "time_published": "20231128T104100",
            "authors": [
                "Cory Renauer"
            ],
            "summary": "With clear advantages over the competition, these divided payers could deliver market-beating gains to patient investors.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F756177%2Findividual-investor-looking-at-stock-charts-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.996675"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.190299,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.053629",
                    "ticker_sentiment_score": "0.057766",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.263373",
                    "ticker_sentiment_score": "0.160978",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WCN",
                    "relevance_score": "0.313484",
                    "ticker_sentiment_score": "0.109445",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Google Alum's Biotech Startup Cradle Raises $24M To Boost AI-Powered Protein Design And Engineering - Alphabet  ( NASDAQ:GOOG ) , Alphabet  ( NASDAQ:GOOGL ) ",
            "url": "https://www.benzinga.com/general/biotech/23/11/35973584/google-alums-biotech-startup-cradle-raises-24m-to-boost-ai-powered-protein-design-and-engineering",
            "time_published": "20231128T101008",
            "authors": [
                "Rounak Jain"
            ],
            "summary": "Netherlands-based biotech startup Cradle has raised $24 million in Series A funding as it looks to boost its protein design and engineering process. What Happened: Cradle's $24 million Series A funding was led by Index Ventures, with Kindred Capital also participating in the round.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Cradle-Biotech-Logo.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.307318,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.230235",
                    "ticker_sentiment_score": "0.277341",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.339356",
                    "ticker_sentiment_score": "0.311837",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TRI",
                    "relevance_score": "0.116348",
                    "ticker_sentiment_score": "0.097208",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.230235",
                    "ticker_sentiment_score": "0.277341",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "This Is What Whales Are Betting On Johnson & Johnson - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/options/23/11/35966772/this-is-what-whales-are-betting-on-johnson-johnson",
            "time_published": "20231127T194609",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Financial giants have made a conspicuous bullish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson JNJ revealed 10 unusual trades. Delving into the details, we found 70% of traders were bullish, while 30% showed bearish tendencies.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.201989,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.08687",
                    "ticker_sentiment_score": "0.143346",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.554916",
                    "ticker_sentiment_score": "0.335578",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Global Advanced Drug Delivery Systems Market To Witness Significant Growth In The Forecast Period - Projected CAGR Of 6% From 2023 To 2027 As Per The Business Research Company's Advanced Drug Delivery Systems Global Market Report 2023",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35962849/global-advanced-drug-delivery-systems-market-to-witness-significant-growth-in-the-forecast-period-",
            "time_published": "20231127T163000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Nov. 27, 2023 ( GLOBE NEWSWIRE ) -- The latest market report from The Business Research Company reveals promising prospects for the global advanced drug delivery systems market.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.382134,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NVS",
                    "relevance_score": "0.051999",
                    "ticker_sentiment_score": "0.178561",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.051999",
                    "ticker_sentiment_score": "0.178561",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HALO",
                    "relevance_score": "0.051999",
                    "ticker_sentiment_score": "0.047686",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.051999",
                    "ticker_sentiment_score": "0.178561",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.051999",
                    "ticker_sentiment_score": "0.178561",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "3 Biotech Stocks To Watch Before December 2023",
            "url": "https://stockmarket.com/featured/3-biotech-stocks-to-watch-before-december-2023-2023-11-27",
            "time_published": "20231127T153843",
            "authors": [
                "Jonathan Phillip"
            ],
            "summary": "The biotechnology sector is a dynamic and innovative field that combines biological sciences with technology. It encompasses a range of companies focusing on medical research, pharmaceuticals, and genetic engineering. These companies work on groundbreaking treatments, vaccines, and technologies.",
            "banner_image": "https://u3j7m9h7.rocketcdn.me/wp-content/uploads/2020/07/REGN-Stock.jpg",
            "source": "StockMarket.com",
            "category_within_source": "n/a",
            "source_domain": "stockmarket.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999896"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999987"
                }
            ],
            "overall_sentiment_score": 0.14494,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "REGN",
                    "relevance_score": "0.296582",
                    "ticker_sentiment_score": "-0.017807",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.296582",
                    "ticker_sentiment_score": "-0.075704",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.296582",
                    "ticker_sentiment_score": "0.136713",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should Vanguard Russell 1000 Value ETF  ( VONV )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2189497/should-vanguard-russell-1000-value-etf-vonv-be-on-your-investing-radar",
            "time_published": "20231127T112005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default151.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.276023,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JPM",
                    "relevance_score": "0.125789",
                    "ticker_sentiment_score": "0.069184",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.063091",
                    "ticker_sentiment_score": "0.060015",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.125789",
                    "ticker_sentiment_score": "0.069184",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "5 Stocks You Can Confidently Invest $500 In Right Now",
            "url": "https://www.fool.com/investing/2023/11/27/5-stocks-you-can-confidently-invest-500-in-now/",
            "time_published": "20231127T103000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "These companies could significantly grow your investment over the long haul.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F756026%2Fgettyimages-woman-points-at-computer-with-a-pen-to-show-something-to-a-colleague.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999346"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.342983,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.089629",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DTST",
                    "relevance_score": "0.044885",
                    "ticker_sentiment_score": "0.1789",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.264419",
                    "ticker_sentiment_score": "0.361995",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.221616",
                    "ticker_sentiment_score": "0.367979",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.221616",
                    "ticker_sentiment_score": "0.201983",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.089629",
                    "ticker_sentiment_score": "0.137094",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Virtualware Appoints John A. Cunningham, COO of VRARA and Former Unity Executive, to International Advisory Board for U.S. Expansion Drive",
            "url": "https://www.globenewswire.com/news-release/2023/11/27/2785842/0/en/Virtualware-Appoints-John-A-Cunningham-COO-of-VRARA-and-Former-Unity-Executive-to-International-Advisory-Board-for-U-S-Expansion-Drive.html",
            "time_published": "20231127T064500",
            "authors": [
                "VIRTUALWARE 2007 SA"
            ],
            "summary": "BILBAO, Spain and MIAMI, November 27, 2023.- Virtualware, a European leader in Virtual Reality solutions, has appointed VR and AR industry leader John A. Cunningham to its International Advisory Board in a move that marks a significant step in Virtualware's U.S. market expansion.",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/6aee44c0-62ac-4f66-9be0-b3578d202005",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.176107,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "HTHIF",
                    "relevance_score": "0.042122",
                    "ticker_sentiment_score": "0.103523",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.042122",
                    "ticker_sentiment_score": "0.157011",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "IBDSF",
                    "relevance_score": "0.042122",
                    "ticker_sentiment_score": "0.103523",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AOMFF",
                    "relevance_score": "0.042122",
                    "ticker_sentiment_score": "0.103523",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.042122",
                    "ticker_sentiment_score": "0.103523",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.042122",
                    "ticker_sentiment_score": "0.103523",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "KENVUE ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses In Kenvue To Contact Him Directly To Discuss Their Options - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35951423/kenvue-ongoing-deadline-alert-faruqi-faruqi-securities-litigation-partner-james-josh-wilson-encour",
            "time_published": "20231126T141500",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "If you purchased or acquired securities in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus ( collectively, the \"Registration Statement\" ) issued in connection with the Company's May 2023 initial public offering ( the \"IPO\" or \"Offering\" ) and ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                }
            ],
            "overall_sentiment_score": 0.1474,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.623692",
                    "ticker_sentiment_score": "0.025572",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.064104",
                    "ticker_sentiment_score": "0.09307",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio",
            "url": "https://www.fool.com/investing/2023/11/26/got-1500-you-can-confidently-add-these-3-stocks-to/",
            "time_published": "20231126T121500",
            "authors": [
                "Matthew DiLallo"
            ],
            "summary": "These companies offer low-risk growth and income at a value price.",
            "banner_image": "https://g.foolcdn.com/editorial/images/756085/a-person-pointing-to-dollar-signs-next-to-a-chart-showing-steady-growth.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.998356"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.838487"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.328289,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SO",
                    "relevance_score": "0.142284",
                    "ticker_sentiment_score": "0.250776",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.324292",
                    "ticker_sentiment_score": "0.388699",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying?",
            "url": "https://www.fool.com/investing/2023/11/26/johnson-johnson-and-intuitive-surgical-might-becom/",
            "time_published": "20231126T113000",
            "authors": [
                "Alex Carchidi"
            ],
            "summary": "With retailers worrying about Ozempic's impact, healthcare stocks could be next.",
            "banner_image": "https://g.foolcdn.com/editorial/images/755827/stressed-investor-sitting-in-dark-at-computer.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.090999,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.120203",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.223659",
                    "ticker_sentiment_score": "0.065413",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "KENVUE DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/kenvue-deadline-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301996260.html",
            "time_published": "20231125T140000",
            "authors": [],
            "summary": "KENVUE DEADLINE ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.16374,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "DCGO",
                    "relevance_score": "0.12165",
                    "ticker_sentiment_score": "0.216175",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.600121",
                    "ticker_sentiment_score": "0.021496",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCLI",
                    "relevance_score": "0.061003",
                    "ticker_sentiment_score": "0.219133",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.061003",
                    "ticker_sentiment_score": "0.093005",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Warren Buffett-Led Berkshire Hathaway Sells Its Entire Procter & Gamble Stake. Should You?",
            "url": "https://www.fool.com/investing/2023/11/25/buffett-berkshire-sell-procter-gamble-stock/",
            "time_published": "20231125T104800",
            "authors": [
                "Daniel Foelber"
            ],
            "summary": "Procter & Gamble has proven it can justify repeated price hikes without overly damaging sales volume.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F755747%2Fgettyimages-1398819387-1200x772-f9fd0c6.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999993"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                }
            ],
            "overall_sentiment_score": 0.224694,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.04882",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UPS",
                    "relevance_score": "0.04882",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.28664",
                    "ticker_sentiment_score": "0.140221",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.04882",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "4 ETFs to Implement Buffett's Investing Philosophy",
            "url": "https://www.zacks.com/stock/news/2189287/4-etfs-to-implement-buffetts-investing-philosophy",
            "time_published": "20231124T184200",
            "authors": [
                "Sanghamitra Saha"
            ],
            "summary": "Warren Buffett is a well-known figure in the global financial world, and it is worthwhile to track his investment portfolio.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ff/944.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.361367,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.159218",
                    "ticker_sentiment_score": "0.365144",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NTRS",
                    "relevance_score": "0.106541",
                    "ticker_sentiment_score": "0.138877",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.159218",
                    "ticker_sentiment_score": "0.233305",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.106541",
                    "ticker_sentiment_score": "0.327357",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.159218",
                    "ticker_sentiment_score": "0.233305",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UPS",
                    "relevance_score": "0.159218",
                    "ticker_sentiment_score": "0.233305",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MORN",
                    "relevance_score": "0.05339",
                    "ticker_sentiment_score": "0.102999",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.05339",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Dividend Stocks You Can Safely Hold for Decades",
            "url": "https://www.fool.com/investing/2023/11/24/3-dividend-stocks-you-can-safely-hold-for-decades/",
            "time_published": "20231124T132000",
            "authors": [
                "Ryan Downie"
            ],
            "summary": "Investors can confidently buy these income stocks for the long term.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F755523%2Fgettyimages-1039705312.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.503496"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.818451"
                }
            ],
            "overall_sentiment_score": 0.306866,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.03878",
                    "ticker_sentiment_score": "0.045084",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.192081",
                    "ticker_sentiment_score": "0.22957",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "EMR",
                    "relevance_score": "0.077468",
                    "ticker_sentiment_score": "0.094187",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.154207",
                    "ticker_sentiment_score": "0.134131",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "71% of Warren Buffett's $357 Billion Portfolio Is Invested in Just 4 Stocks",
            "url": "https://www.fool.com/investing/2023/11/24/71-warren-buffett-portfolio-invested-in-4-stocks/",
            "time_published": "20231124T100600",
            "authors": [
                "Sean Williams"
            ],
            "summary": "A whopping $252 billion of Berkshire Hathaway's $357 billion of invested assets can be traced to four brand-name businesses.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F755548%2Fbuffett11-tmf.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.779048"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.29069,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.030446",
                    "ticker_sentiment_score": "0.08928",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.297301",
                    "ticker_sentiment_score": "0.315811",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.181137",
                    "ticker_sentiment_score": "0.128481",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.268786",
                    "ticker_sentiment_score": "0.159165",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.121343",
                    "ticker_sentiment_score": "0.124895",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.030446",
                    "ticker_sentiment_score": "0.135671",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.030446",
                    "ticker_sentiment_score": "0.135671",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.210666",
                    "ticker_sentiment_score": "0.160113",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Underdeveloped nations fighting drugmakers over access to TB, HIV drugs",
            "url": "https://www.business-standard.com/world-news/underdeveloped-nations-fighting-drugmakers-over-access-to-tb-hiv-drugs-123112400284_1.html",
            "time_published": "20231124T072501",
            "authors": [
                "AP"
            ],
            "summary": "South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.",
            "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2023-05/03/full/1683122654-0391.jpg?im=FitAndFill=(826,465)",
            "source": "Business Standard",
            "category_within_source": "GoogleRSS",
            "source_domain": "www.business-standard.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.074593,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.035241",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.035241",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.035241",
                    "ticker_sentiment_score": "0.008844",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs",
            "url": "https://apnews.com/article/bedaquiline-dolutegravir-tuberculosis-hiv-south-africa-0f6de15ea57279b699c147c015b23c02",
            "time_published": "20231124T050700",
            "authors": [
                "MARIA CHENG",
                "GERALD IMRAY"
            ],
            "summary": "CAPE TOWN, South Africa ( AP ) - South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.",
            "banner_image": "https://dims.apnews.com/dims4/default/5926877/2147483647/strip/true/crop/3176x2116+0+1/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2F16%2F0f%2Fcb41a0d9801e064e795df24a6527%2Fa50210d3d5b048fc80c9e2df56d39a98",
            "source": "Associated Press",
            "category_within_source": "Business",
            "source_domain": "apnews.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.062535,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.035661",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.035661",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.035661",
                    "ticker_sentiment_score": "0.008854",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Burn Care Market to grow by USD 843.34 million from 2022 to 2027; North America to account for 35% of market ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/burn-care-market-to-grow-by-usd-843-34-million-from-2022-to-2027-north-america-to-account-for-35-of-market-growth--technavio-301996767.html",
            "time_published": "20231124T041500",
            "authors": [],
            "summary": "Burn Care Market to grow by USD 843.34 million from 2022 to 2027. North America to account for 35% of market ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.097605,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ETTYF",
                    "relevance_score": "0.064276",
                    "ticker_sentiment_score": "0.097542",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.064276",
                    "ticker_sentiment_score": "0.097542",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAH",
                    "relevance_score": "0.064276",
                    "ticker_sentiment_score": "0.097542",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.128135",
                    "ticker_sentiment_score": "0.077629",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLPBY",
                    "relevance_score": "0.064276",
                    "ticker_sentiment_score": "0.097542",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNVVF",
                    "relevance_score": "0.064276",
                    "ticker_sentiment_score": "0.097542",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANIK",
                    "relevance_score": "0.064276",
                    "ticker_sentiment_score": "0.097542",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.064276",
                    "ticker_sentiment_score": "0.097542",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.064276",
                    "ticker_sentiment_score": "0.097542",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BOIRF",
                    "relevance_score": "0.064276",
                    "ticker_sentiment_score": "0.097542",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IART",
                    "relevance_score": "0.064276",
                    "ticker_sentiment_score": "0.097542",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.064276",
                    "ticker_sentiment_score": "0.097542",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VCEL",
                    "relevance_score": "0.064276",
                    "ticker_sentiment_score": "0.097542",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Cell Surface Markers Market size to grow by USD 14.06 billion from 2023-2028| Abbott Laboratories, Abcam plc ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/cell-surface-markers-market-size-to-grow-by-usd-14-06-billion-from-2023-2028-abbott-laboratories-abcam-plc-agilent-technologies-inc-and-more-among-the-key-companies-in-the-market---technavio-301996069.html",
            "time_published": "20231123T013000",
            "authors": [],
            "summary": "Cell Surface Markers Market size to grow by USD 14.06 billion from 2023-2028| Abbott Laboratories, Abcam plc ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.267764,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "A",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSMXF",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIO",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SEMHF",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DHR",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TECH",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABCM",
                    "relevance_score": "0.129168",
                    "ticker_sentiment_score": "0.040782",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BDX",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GNNSF",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TMO",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSRLF",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GRFS",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QGEN",
                    "relevance_score": "0.064797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight",
            "url": "https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-b-cell-lymphomas-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-mantle-cell-lymphoma-marginal-zone-lymphoma-waldenstrom-macroglobulinemia-and-burkitt-lymphoma--301995626.html",
            "time_published": "20231122T220100",
            "authors": [
                "DelveInsight Business Research",
                "LLP"
            ],
            "summary": "The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.129719,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "IPHA",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "-0.019011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.026023",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RSSS",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.120239",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SKXJF",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "-0.019011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DAWN",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.040164",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INO",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.040164",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSKYF",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "-0.019011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRTX",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "-0.019011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.026023",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SWTX",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.040164",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CGEM",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "-0.019011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRTHF",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.026023",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNSP",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.040164",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCCC",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.026023",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BGNE",
                    "relevance_score": "0.026343",
                    "ticker_sentiment_score": "0.037824",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KZIA",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.040164",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.039505",
                    "ticker_sentiment_score": "0.102193",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.052656",
                    "ticker_sentiment_score": "0.017928",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CMRX",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.040164",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACLX",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.026023",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VBIV",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.040164",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BYSI",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "-0.019011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RAIN",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "-0.019011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IOVA",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "-0.019011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.039505",
                    "ticker_sentiment_score": "0.022299",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TIL",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "-0.019011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RNAC",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.026023",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INCY",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.040164",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KPTI",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.040164",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KTRA",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.040164",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.039505",
                    "ticker_sentiment_score": "-0.000967",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RVMD",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "-0.019011",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.013173",
                    "ticker_sentiment_score": "0.040164",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Market Whales and Their Recent Bets on JNJ Options - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/options/23/11/35923874/market-whales-and-their-recent-bets-on-jnj-options",
            "time_published": "20231122T194621",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Financial giants have made a conspicuous bearish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson JNJ revealed 10 unusual trades. Delving into the details, we found 40% of traders were bullish, while 60% showed bearish tendencies.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.125306,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.142726",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.605266",
                    "ticker_sentiment_score": "0.313831",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc.  ( KVUE )  - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35921447/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains",
            "time_published": "20231122T173636",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LOS ANGELES, Nov. 22, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( \"GPM\" ) reminds investors of the upcoming December 8, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Kenvue Inc. ( \"Kenvue\" or the ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.021733,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.612343",
                    "ticker_sentiment_score": "0.039842",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.062597",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.062597",
                    "ticker_sentiment_score": "0.086023",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Skin Care Products Market Estimated to Reach USD 269.2 billion by 2031 Globally, at a CAGR of 5.6 % | Says Transparency Market Research Inc.",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35920040/skin-care-products-market-estimated-to-reach-usd-269-2-billion-by-2031-globally-at-a-cagr-of-5-6-s",
            "time_published": "20231122T163000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Nov. 22, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The skin care products market stood at US$ 156 billion in 2021 and the global market is projected to reach US$ 269.2 billion in 2031.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.362412,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.039811",
                    "ticker_sentiment_score": "0.084204",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.039811",
                    "ticker_sentiment_score": "0.220798",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Worried About Market Volatility? Invest In These High-Yield Dividend Stocks For Consistent Passive Income - Johnson & Johnson  ( NYSE:JNJ ) , NextEra Energy  ( NYSE:NEE ) ",
            "url": "https://www.benzinga.com/trading-ideas/dividends/23/11/35919184/worried-about-market-volatility-invest-in-these-high-yield-dividend-stocks-for-consistent",
            "time_published": "20231122T160118",
            "authors": [
                "Aditi Ganguly"
            ],
            "summary": "While the stock market has been recovering since the pullback last year, market volatility remains high as geopolitical tensions persist. The recent crisis in the Middle East has sparked concerns regarding broader regional instability.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Interest-Rates-And-Dividends--Business-P.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999864"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.928769"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.189976,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SRC",
                    "relevance_score": "0.047371",
                    "ticker_sentiment_score": "0.171624",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KMI",
                    "relevance_score": "0.047371",
                    "ticker_sentiment_score": "0.029972",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.047371",
                    "ticker_sentiment_score": "0.087847",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.322474",
                    "ticker_sentiment_score": "0.321932",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NEE",
                    "relevance_score": "0.233556",
                    "ticker_sentiment_score": "0.098478",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "O",
                    "relevance_score": "0.187827",
                    "ticker_sentiment_score": "0.234202",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.047371",
                    "ticker_sentiment_score": "-0.077656",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Zacks Analyst Blog Highlights Novo Nordisk Bank of America, Netflix, Johnson & Johnson and TotalEnergies",
            "url": "https://www.zacks.com/stock/news/2187835/the-zacks-analyst-blog-highlights-novo-nordisk-bank-of-america-netflix-johnson-johnson-and-totalenergies",
            "time_published": "20231122T144300",
            "authors": [
                "Zacks Investment Research"
            ],
            "summary": "Novo Nordisk, Bank of America, Netflix, Johnson & Johnson and TotalEnergies are part of the Zacks top Analyst Blog.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/23/20486.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.217174,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.259727",
                    "ticker_sentiment_score": "0.19722",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.259727",
                    "ticker_sentiment_score": "0.075557",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TTE",
                    "relevance_score": "0.131643",
                    "ticker_sentiment_score": "0.036445",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.321393",
                    "ticker_sentiment_score": "0.188024",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.066047",
                    "ticker_sentiment_score": "-0.018282",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.131643",
                    "ticker_sentiment_score": "0.036445",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Need a path to your dream profession? Rutgers Business School offers a roadmap to success",
            "url": "https://www.prnewswire.com/news-releases/need-a-path-to-your-dream-profession-rutgers-business-school-offers-a-roadmap-to-success-301995139.html",
            "time_published": "20231122T141500",
            "authors": [
                "Rutgers Business School-Newark and New Brunswick"
            ],
            "summary": "NEW BRUNSWICK, N.J., Nov. 22, 2023 /PRNewswire/ -- For Eric Yao, a high school student in Rockville, Maryland, Rutgers Business School offered proximity to New York City ( \"the capital of the world,\" as he put it ) , an extremely large alumni network and the opportunity to study at a tier-one ...",
            "banner_image": "https://mma.prnewswire.com/media/2282982/Rutgers_Business_School_students_meet_alumni.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.313803,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.021013",
                    "ticker_sentiment_score": "0.064125",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.042011",
                    "ticker_sentiment_score": "0.169902",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.021013",
                    "ticker_sentiment_score": "0.271408",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.021013",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.021013",
                    "ticker_sentiment_score": "0.135909",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UL",
                    "relevance_score": "0.021013",
                    "ticker_sentiment_score": "0.135909",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PCRFF",
                    "relevance_score": "0.021013",
                    "ticker_sentiment_score": "0.135909",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CL",
                    "relevance_score": "0.021013",
                    "ticker_sentiment_score": "0.135909",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACN",
                    "relevance_score": "0.021013",
                    "ticker_sentiment_score": "-0.043579",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.021013",
                    "ticker_sentiment_score": "0.132155",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.021013",
                    "ticker_sentiment_score": "0.135909",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.021013",
                    "ticker_sentiment_score": "0.135909",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "AbelZeta Announces Two Abstracts Accepted for Presentation at the 65th ASH Annual Meeting",
            "url": "https://www.prnewswire.com/news-releases/abelzeta-announces-two-abstracts-accepted-for-presentation-at-the-65th-ash-annual-meeting-301995912.html",
            "time_published": "20231122T140000",
            "authors": [
                "Inc.",
                "AbelZeta Pharma"
            ],
            "summary": "ROCKVILLE, Md. and SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- AbelZeta Pharma, Inc. ( \"AbelZeta\" or the \"Company\" ) , a global clinical-stage biopharmaceutical company focused on discovery and development of innovative and proprietary cell-based therapeutic products, announced today that two ...",
            "banner_image": "https://mma.prnewswire.com/media/2281429/AbelZeta_Pharma_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.061917,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.062271",
                    "ticker_sentiment_score": "0.199181",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "How Viz.ai Uses Artificial Intelligence To Treat Stroke Patients Faster",
            "url": "https://www.forbes.com/sites/amyfeldman/2023/11/22/how-vizai-uses-artificial-intelligence-to-speed-help-to-stroke-patients/",
            "time_published": "20231122T113000",
            "authors": [
                "Amy Feldman"
            ],
            "summary": "The startup has 12 FDA-approved algorithms to flag problems, agreements with more than 1,500 U.S. hospitals, and big plans to work with drug companies to reduce roadblocks in healthcare. October 26, while visiting New York City for a gala, Jess Allison collapsed on the street.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/655befc25c58c309b24c36c0/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.135382,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.033918",
                    "ticker_sentiment_score": "0.091434",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.016963",
                    "ticker_sentiment_score": "0.108781",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "THC",
                    "relevance_score": "0.016963",
                    "ticker_sentiment_score": "0.08534",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.033918",
                    "ticker_sentiment_score": "0.127825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.016963",
                    "ticker_sentiment_score": "0.108781",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.016963",
                    "ticker_sentiment_score": "0.005995",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?",
            "url": "https://www.zacks.com/stock/news/2187631/should-you-invest-in-the-health-care-select-sector-spdr-etf-xlv",
            "time_published": "20231122T112006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default50.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.301216,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.126784",
                    "ticker_sentiment_score": "0.060142",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.063594",
                    "ticker_sentiment_score": "0.127366",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STT",
                    "relevance_score": "0.063594",
                    "ticker_sentiment_score": "0.089049",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.126784",
                    "ticker_sentiment_score": "0.060142",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.126784",
                    "ticker_sentiment_score": "0.060142",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Biotech Stocks That Could Be Millionaire Makers",
            "url": "https://www.fool.com/investing/2023/11/22/3-biotech-stocks-that-could-be-millionaire-makers/",
            "time_published": "20231122T103000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "Many biotech stocks offer exciting long-term growth prospects.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F755778%2Fgettyimages-667652037.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.87644"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.272056,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.054983",
                    "ticker_sentiment_score": "0.060844",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.054983",
                    "ticker_sentiment_score": "0.257973",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.269776",
                    "ticker_sentiment_score": "0.070063",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JAZZ",
                    "relevance_score": "0.054983",
                    "ticker_sentiment_score": "0.039877",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXSM",
                    "relevance_score": "0.109705",
                    "ticker_sentiment_score": "0.043593",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.054983",
                    "ticker_sentiment_score": "0.257973",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "5 Longtime Holdings Warren Buffett Completely Sold During the Third Quarter",
            "url": "https://www.fool.com/investing/2023/11/22/5-longtime-holdings-warren-buffett-sold-during-q3/",
            "time_published": "20231122T100600",
            "authors": [
                "Sean Williams"
            ],
            "summary": "These brand-name companies had been fixtures in Berkshire Hathaway's portfolio for the past 11 to 18 years.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F755554%2Fbuffett9-tmf.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999186"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.105279,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.167904",
                    "ticker_sentiment_score": "0.035403",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.222582",
                    "ticker_sentiment_score": "0.124177",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.112401",
                    "ticker_sentiment_score": "0.090821",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.112401",
                    "ticker_sentiment_score": "-0.043518",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KHC",
                    "relevance_score": "0.028188",
                    "ticker_sentiment_score": "-0.006538",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.084423",
                    "ticker_sentiment_score": "0.015696",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UPS",
                    "relevance_score": "0.222582",
                    "ticker_sentiment_score": "0.123586",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AWON",
                    "relevance_score": "0.028188",
                    "ticker_sentiment_score": "0.021373",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.028188",
                    "ticker_sentiment_score": "0.026673",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "How Is The Market Feeling About Johnson & Johnson? - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/short-sellers/23/11/35903915/how-is-the-market-feeling-about-johnson-johnson",
            "time_published": "20231121T191512",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Johnson & Johnson's JNJ short percent of float has fallen 7.69% since its last report. The company recently reported that it has 14.53 million shares sold short, which is 0.6% of all regular shares that are available for trading.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.237013,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.221819",
                    "ticker_sentiment_score": "0.081322",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "J&J  ( JNJ )  Seeks Expanded Use of Lung Cancer Drug Rybrevant",
            "url": "https://www.zacks.com/stock/news/2187470/jj-jnj-seeks-expanded-use-of-lung-cancer-drug-rybrevant",
            "time_published": "20231121T174100",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "J&J's (JNJ) sBLA seeks label expansion for Rybrevant plus chemotherapy to treat patients with EGFR-mutated NSCLC whose disease progressed on or after treatment with AstraZeneca's Tagrisso (osimertinib).",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ed/4040.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.9973"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.201274,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.356609",
                    "ticker_sentiment_score": "0.177221",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ACAD",
                    "relevance_score": "0.421485",
                    "ticker_sentiment_score": "0.129066",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.356609",
                    "ticker_sentiment_score": "0.167325",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.146916",
                    "ticker_sentiment_score": "-0.044802",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "4 Best High Yield Dividend Stocks For Retirement Portfolios",
            "url": "https://www.forbes.com/sites/investor-hub/article/best-high-yield-dividend-stocks-for-retirement-portfolios/",
            "time_published": "20231121T170355",
            "authors": [
                "Rob Isbitts"
            ],
            "summary": "Dividend stocks are a core part of many retirement portfolios. But dividend investing is at a unique point in market history, with T-bills yielding 5%. That raises the bar for \"high-yield\" stocks, since stocks can fall heavily in price. In this article, I toe the line between yield and stability.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65088adaf52b8ed2812250b8/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                }
            ],
            "overall_sentiment_score": 0.209817,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.024077",
                    "ticker_sentiment_score": "0.199822",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CVX",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.110967",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.1437",
                    "ticker_sentiment_score": "0.189794",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "IBM",
                    "relevance_score": "0.1437",
                    "ticker_sentiment_score": "0.16196",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.024077",
                    "ticker_sentiment_score": "-0.071185",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.11995",
                    "ticker_sentiment_score": "0.152743",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Drexel University BrandVoice: Is College Still Worthwhile? Yes, When It's Tied To Experiences",
            "url": "https://www.forbes.com/sites/drexeluniversity/2023/11/21/is-college-still-worthwhile-yes-when-its-tied-to-experiences/",
            "time_published": "20231121T144853",
            "authors": [
                "Drexel University Contributor"
            ],
            "summary": "Is College Still Worthwhile? Yes, When It's Tied To Experiences Forbes ...",
            "banner_image": "https://blogs-images.forbes.com/assets/images/avatars/blog-6633_400_ca9e0040bddda6c3f8e2c8d9a2d79021.jpg",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.262714,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PRFUF",
                    "relevance_score": "0.024546",
                    "ticker_sentiment_score": "0.078137",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.024546",
                    "ticker_sentiment_score": "0.150008",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DASH",
                    "relevance_score": "0.024546",
                    "ticker_sentiment_score": "0.07572",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.024546",
                    "ticker_sentiment_score": "0.061016",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.024546",
                    "ticker_sentiment_score": "0.076643",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Kenvue Shareholder Action Reminder",
            "url": "https://markets.businessinsider.com/news/stocks/kenvue-shareholder-action-reminder-1032725577",
            "time_published": "20231121T140900",
            "authors": [
                "NEWSFILE"
            ],
            "summary": "Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Kenvue To Contact Him Directly To Discuss Their Options",
            "banner_image": "https://api.newsfilecorp.com/newsinfo/188093/208",
            "source": "Business Insider",
            "category_within_source": "RSS",
            "source_domain": "markets.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.614606"
                }
            ],
            "overall_sentiment_score": 0.141216,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.650245",
                    "ticker_sentiment_score": "-0.003752",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.06211",
                    "ticker_sentiment_score": "0.093019",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the iShares U.S. Healthcare ETF  ( IYH ) ?",
            "url": "https://www.zacks.com/stock/news/2187024/should-you-invest-in-the-ishares-us-healthcare-etf-iyh",
            "time_published": "20231121T112006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default135.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.251101,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "0.088211",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.070304",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.070304",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.070304",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Sports medicine market size to grow by USD 2.64 billion from 2022 to 2027|Alimed Inc., Arthrex Inc., Bauerfeind AG ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/sports-medicine-market-size-to-grow-by-usd-2-64-billion-from-2022-to-2027alimed-inc-arthrex-inc-bauerfeind-ag-breg-inc-and-more-among-the-key-companies-in-the-market---technavio-301993965.html",
            "time_published": "20231121T091500",
            "authors": [],
            "summary": "Sports medicine market size to grow by USD 2.64 billion from 2022 to 2027|Alimed Inc., Arthrex Inc., Bauerfeind AG ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.134377,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.059049",
                    "ticker_sentiment_score": "0.013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.059049",
                    "ticker_sentiment_score": "0.013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.059049",
                    "ticker_sentiment_score": "0.013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.059049",
                    "ticker_sentiment_score": "0.013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.059049",
                    "ticker_sentiment_score": "0.013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.059049",
                    "ticker_sentiment_score": "0.013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNMD",
                    "relevance_score": "0.059049",
                    "ticker_sentiment_score": "0.013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OSSFF",
                    "relevance_score": "0.059049",
                    "ticker_sentiment_score": "0.013",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Kenvue Inc. Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds KVUE Investors of Securities Fraud Class Action Lawsuit Filed on Their Behalf - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35886105/kenvue-inc-shareholder-reminder-kessler-topaz-meltzer-check-llp-reminds-kvue-investors-of-securiti",
            "time_published": "20231121T005200",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "RADNOR, Pa., Nov. 20, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Kenvue Inc. ( \"Kenvue\" ) KVUE. ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": 0.096895,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.524949",
                    "ticker_sentiment_score": "-0.016687",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.056943",
                    "ticker_sentiment_score": "0.129956",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Behind the Scenes of Johnson & Johnson's Latest Options Trends - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/options/23/11/35877616/behind-the-scenes-of-johnson-johnsons-latest-options-trends",
            "time_published": "20231120T170058",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Whales with a lot of money to spend have taken a noticeably bearish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 12 trades. If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.158007,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.080188",
                    "ticker_sentiment_score": "0.141564",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.579393",
                    "ticker_sentiment_score": "0.305205",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Janssen Submits Supplemental Biologics License Application to U.S. FDA Seeking Approval of RYBREVANT®  ( amivantamab-vmjw )  Plus Chemotherapy for the Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer Who Progressed on or after Osimertinib",
            "url": "https://www.prnewswire.com/news-releases/janssen-submits-supplemental-biologics-license-application-to-us-fda-seeking-approval-of-rybrevant-amivantamab-vmjw-plus-chemotherapy-for-the-treatment-of-patients-with-egfr-mutated-non-small-cell-lung-cancer-who-progressed-o-301993484.html",
            "time_published": "20231120T130100",
            "authors": [
                "The Janssen Pharmaceutical Companies of Johnson & Johnson"
            ],
            "summary": "Janssen Submits Supplemental Biologics License Application to U.S. FDA Seeking Approval of RYBREVANT ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/2193913/jsn_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.002422,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.082272",
                    "ticker_sentiment_score": "0.020891",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Warren Buffett's Berkshire Hathaway Sold $7 Billion Worth of Stock Last Quarter but Bought 1 Mystery Stock",
            "url": "https://www.fool.com/investing/2023/11/20/buffett-berkshire-hathaway-mystery-stock/",
            "time_published": "20231120T112000",
            "authors": [
                "Adam Levy"
            ],
            "summary": "The SEC let Buffett and his team keep this one a secret.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F755427%2Fbuffett2-tmf.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999956"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                }
            ],
            "overall_sentiment_score": 0.26383,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AON",
                    "relevance_score": "0.092213",
                    "ticker_sentiment_score": "0.173201",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.046184",
                    "ticker_sentiment_score": "0.042425",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BATRA",
                    "relevance_score": "0.046184",
                    "ticker_sentiment_score": "0.089913",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GL",
                    "relevance_score": "0.092213",
                    "ticker_sentiment_score": "0.173201",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.046184",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.137934",
                    "ticker_sentiment_score": "0.193503",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.046184",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.046184",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.046184",
                    "ticker_sentiment_score": "0.042425",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UPS",
                    "relevance_score": "0.046184",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SIRI",
                    "relevance_score": "0.137934",
                    "ticker_sentiment_score": "0.2173",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Researchers return to Alzheimer's vaccines, buoyed by recent drug success",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/researchers-return-alzheimers-vaccines-buoyed-by-recent-drug-success-2023-11-20/",
            "time_published": "20231120T111500",
            "authors": [
                "Julie Steenhuysen"
            ],
            "summary": "A doctor points out evidence of Alzheimer's disease on PET scans at the Center for Alzheimer Research and Treatment ( CART ) at Brigham And Women's Hospital in Boston, Massachusetts, U.S., March 30, 2023. REUTERS/Brian Snyder/File photo Acquire Licensing Rights",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/44DLHLDT6NLKRBD4B3LGYE2GVM.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.077594,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ACIU",
                    "relevance_score": "0.083251",
                    "ticker_sentiment_score": "-0.021977",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PRTA",
                    "relevance_score": "0.165598",
                    "ticker_sentiment_score": "0.084646",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VAXX",
                    "relevance_score": "0.124593",
                    "ticker_sentiment_score": "0.108971",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "-0.028824",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "-0.290871",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Meet the Brand-New Value Stock Warren Buffett Is Piling Into",
            "url": "https://www.fool.com/investing/2023/11/20/meet-new-value-stock-warren-buffett-is-piling-into/",
            "time_published": "20231120T100600",
            "authors": [
                "Sean Williams"
            ],
            "summary": "The new apple of the Oracle of Omaha's eye is historically cheap.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F755174%2Fbuffett17-tmf.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.977154"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.905476"
                }
            ],
            "overall_sentiment_score": 0.073199,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "UPS",
                    "relevance_score": "0.081138",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SIRI",
                    "relevance_score": "0.666827",
                    "ticker_sentiment_score": "0.194043",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.040622",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.081138",
                    "ticker_sentiment_score": "0.076338",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.040622",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.040622",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Interventional Spine Devices Market to grow by USD 3.07 billion from 2023 to 2028; North America to account for 47 ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/interventional-spine-devices-market-to-grow-by-usd-3-07-billion-from-2023-to-2028-north-america-to-account-for-47-of-market-growth--technavio-301992857.html",
            "time_published": "20231120T063500",
            "authors": [],
            "summary": "Interventional Spine Devices Market to grow by USD 3.07 billion from 2023 to 2028. North America to account for 47 ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.142199,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MFCSF",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.131444",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MMSI",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OFIX",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.140485",
                    "ticker_sentiment_score": "-0.25256",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "GMED",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IART",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kenvue, Inc. of Class Action Lawsuit and Upcoming Deadline - KVUE",
            "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-kenvue-inc-of-class-action-lawsuit-and-upcoming-deadline--kvue-301992543.html",
            "time_published": "20231119T191500",
            "authors": [
                "Pomerantz LLP"
            ],
            "summary": "SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kenvue, Inc ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/1486339/Pomerantz_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.990678"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.95493"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.021646,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.511465",
                    "ticker_sentiment_score": "-0.051849",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.171363",
                    "ticker_sentiment_score": "0.01387",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "KENVUE ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses In Kenvue To Contact Him Directly To Discuss Their Options - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35865247/kenvue-ongoing-deadline-alert-faruqi-faruqi-securities-litigation-partner-james-josh-wilson-encour",
            "time_published": "20231119T150000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "If you purchased or acquired securities in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus ( collectively, the \"Registration Statement\" ) issued in connection with the Company's May 2023 initial public offering ( the \"IPO\" or \"Offering\" ) and ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                }
            ],
            "overall_sentiment_score": 0.147395,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.623692",
                    "ticker_sentiment_score": "0.025571",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.064104",
                    "ticker_sentiment_score": "0.091067",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Legendary value investor's firm launches new fund targeting 'quality' stocks",
            "url": "https://www.cnbc.com/2023/11/18/legendary-investors-firm-launches-new-fund-targeting-quality-stocks.html",
            "time_published": "20231118T210352",
            "authors": [
                "Emily Glass"
            ],
            "summary": "The money manager behind legendary investor Jeremy Grantham's GMO U.S. Quality ETF delivers his strategy for gains.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107333110-1699910116ETF-SEG1-111323.jpg?v=1699910116&w=750&h=422&vtcrop=y",
            "source": "CNBC",
            "category_within_source": "Finance",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.938238"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.446968,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.254307",
                    "ticker_sentiment_score": "0.14576",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.254307",
                    "ticker_sentiment_score": "0.14576",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.254307",
                    "ticker_sentiment_score": "0.14576",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "KVUE CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Kenvue Inc.  ( KVUE )  Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to...",
            "url": "https://markets.businessinsider.com/news/stocks/kvue-class-action-notice-kessler-topaz-meltzer-check-llp-reminds-kenvue-inc.-kvue-shareholders-of-securities-fraud-class-action-lawsuit-and-encourages-investors-with-substantial-losses-to-contact-the-firm-1032833108",
            "time_published": "20231118T140600",
            "authors": [
                "NEWSFILE"
            ],
            "summary": "KVUE CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Kenvue Inc. (KVUE) Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to...",
            "banner_image": "https://api.newsfilecorp.com/newsinfo/187919/208",
            "source": "Business Insider",
            "category_within_source": "RSS",
            "source_domain": "markets.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                }
            ],
            "overall_sentiment_score": 0.106735,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.620083",
                    "ticker_sentiment_score": "-0.014627",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.05833",
                    "ticker_sentiment_score": "0.134996",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "KENVUE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/kenvue-shareholder-action-reminder-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301992692.html",
            "time_published": "20231118T140000",
            "authors": [],
            "summary": "KENVUE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James ( Josh ) Wilson Encourages ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.1637,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.597724",
                    "ticker_sentiment_score": "0.021452",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INSE",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "0.219113",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "0.093002",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Personal Care Industry Poised For Growth: Analyst Initiates Coverage On These 3 Stocks - Kimberly-Clark  ( NYSE:KMB ) , Kenvue  ( NYSE:KVUE ) , Perrigo  ( NYSE:PRGO ) ",
            "url": "https://www.benzinga.com/markets/equities/23/11/35853309/personal-care-industry-poised-for-growth-analyst-initiates-coverage-on-these-3-stocks",
            "time_published": "20231117T195420",
            "authors": [
                "Lekha Gupta"
            ],
            "summary": "Piper Sandler analyst Korinne Wolfmeyer initiated coverage on several personal care stocks, noting that amid the present economic conditions, consumers are becoming more discerning in their spending. This positions the personal care category favorably for the near and mid-term, due to its ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/17/personal_care_shutter.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.274598,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.412861",
                    "ticker_sentiment_score": "0.13812",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMB",
                    "relevance_score": "0.316168",
                    "ticker_sentiment_score": "0.344508",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.107978",
                    "ticker_sentiment_score": "-0.054832",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PRGO",
                    "relevance_score": "0.412861",
                    "ticker_sentiment_score": "0.176365",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Resolves 2 Major Talc Cases As Legal Battles Continue - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/news/large-cap/23/11/35845493/johnson-johnson-resolves-2-major-talc-cases-as-legal-battles-continue",
            "time_published": "20231117T142524",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Johnson & Johnson JNJ announced settlements in two talc-related cases, the news follows an appeals court's ruling which overturned a $223.8 million verdict against the company. The company is facing over 50,000 talc-related lawsuits, primarily from women with ovarian cancer, and maintains its ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/17/aapharma_1.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.002423,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.386875",
                    "ticker_sentiment_score": "0.23944",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "13F Rundown: Tepper, Buffett, Druckenmiller",
            "url": "https://www.zacks.com/commentary/2185646/13f-rundown-tepper-buffett-druckenmiller",
            "time_published": "20231117T130000",
            "authors": [
                "Andrew Rocco"
            ],
            "summary": "Stock Strategist Andrew Rocco divulges valuable insights from the world's best and brightest investors.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/1d/26991.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.918141"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.234041,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BABA",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.196542",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "0.208936",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.196542",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.354572",
                    "ticker_sentiment_score": "0.244913",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.206432",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "-0.052481",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.206432",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.206432",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.074495",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CPNG",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.074495",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "0.196542",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TCKRF",
                    "relevance_score": "0.073321",
                    "ticker_sentiment_score": "0.058869",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Warren Buffett, Ray Dalio's Hedge Funds Are Selling Top-Ranking Dividend King - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/equities/23/11/35846742/why-warren-buffett-ray-dalios-hedge-funds-are-selling-top-ranking-dividend-king",
            "time_published": "20231117T125837",
            "authors": [
                "Surbhi Jain"
            ],
            "summary": "One top-ranked dividend king was a popular sell amid hedge fund billionaires in the third quarter this year. This fact came to light in recent 13F filings from the whales of Wall Street. Johnson & Johnson JNJ is among the biggest pharmaceutical companies worldwide, with approximately 130,000 ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Johnson-amp-Johnson-COVID-19-vaccine.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.503496"
                }
            ],
            "overall_sentiment_score": 0.139335,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AB",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.155912",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.87799",
                    "ticker_sentiment_score": "0.405623",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Should Vanguard High Dividend Yield ETF  ( VYM )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2185771/should-vanguard-high-dividend-yield-etf-vym-be-on-your-investing-radar",
            "time_published": "20231117T112007",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default204.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.204267,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JPM",
                    "relevance_score": "0.125134",
                    "ticker_sentiment_score": "0.069019",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.125134",
                    "ticker_sentiment_score": "0.069019",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.125134",
                    "ticker_sentiment_score": "0.069019",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson Is Eyeing Intuitive Surgical's Market, But Can It Win?",
            "url": "https://www.fool.com/investing/2023/11/17/johnson-johnson-eyeing-intuitive-surgicals-market/",
            "time_published": "20231117T110300",
            "authors": [
                "Alex Carchidi"
            ],
            "summary": "The healthcare company's entry into the market will be a major test for Intuitive Surgical.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.136741,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MDT",
                    "relevance_score": "0.045139",
                    "ticker_sentiment_score": "-0.103775",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.265859",
                    "ticker_sentiment_score": "0.022151",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.222838",
                    "ticker_sentiment_score": "0.08142",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion - Tesla  ( NASDAQ:TSLA ) ",
            "url": "https://www.benzinga.com/markets/equities/23/11/35843401/senators-bearish-tesla-bet-under-scrutiny-as-he-buys-put-options-ahead-of-elon-musk-led-companys",
            "time_published": "20231117T070236",
            "authors": [
                "Shanthi Rexaline"
            ],
            "summary": "Tesla, Inc. TSLA shares have been going through a lean phase and the modest recovery seen has been in fits-and-starts. Against this backdrop, a Congressman has disclosed on Thursday bearish bets on the electric vehicle giant. What Happened: Sen.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Us-Senator-Tommy-Tuberville-Speaks-On-Th.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999186"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.106972,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.134306",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NXPI",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RMD",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CSX",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.134306",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.134306",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "-0.140547",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ROK",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.449219",
                    "ticker_sentiment_score": "0.145674",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PHM",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMS",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WU",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NSC",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.134306",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ODFL",
                    "relevance_score": "0.135347",
                    "ticker_sentiment_score": "0.134306",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:BGN",
                    "relevance_score": "0.067919",
                    "ticker_sentiment_score": "0.335235",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis Pigmentosa Market, Limbal Stem Cell Deficiency Market, Leber Hereditary Optic Neuropathy Market, and Stargardt Disease Market | DelveInsight",
            "url": "https://www.prnewswire.com/news-releases/unraveling-the-shifting-rare-eye-diseases-market-landscape-analysis-of-retinoblastoma-market-retinitis-pigmentosa-market-limbal-stem-cell-deficiency-market-leber-hereditary-optic-neuropathy-market-and-stargardt-disease-market-301991311.html",
            "time_published": "20231116T220100",
            "authors": [
                "LLP",
                "DelveInsight Business Research"
            ],
            "summary": "Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.179471,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ABT",
                    "relevance_score": "0.01645",
                    "ticker_sentiment_score": "0.006093",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GENE",
                    "relevance_score": "0.01645",
                    "ticker_sentiment_score": "0.033555",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.01645",
                    "ticker_sentiment_score": "0.006093",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EDIT",
                    "relevance_score": "0.01645",
                    "ticker_sentiment_score": "0.033555",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MGTX",
                    "relevance_score": "0.01645",
                    "ticker_sentiment_score": "0.033555",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NHPEF",
                    "relevance_score": "0.01645",
                    "ticker_sentiment_score": "0.221029",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.01645",
                    "ticker_sentiment_score": "0.006093",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AGTC",
                    "relevance_score": "0.01645",
                    "ticker_sentiment_score": "0.033555",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HCSG",
                    "relevance_score": "0.01645",
                    "ticker_sentiment_score": "0.10478",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.01645",
                    "ticker_sentiment_score": "0.006093",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.01645",
                    "ticker_sentiment_score": "0.006093",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Charlie Munger blasts 'ridiculous' idea that Warren Buffett enriched himself at his shareholders' expense",
            "url": "https://africa.businessinsider.com/markets/charlie-munger-blasts-ridiculous-idea-that-warren-buffett-enriched-himself-at-his/80gbstd",
            "time_published": "20231116T170612",
            "authors": [
                "Theron Mohamed"
            ],
            "summary": "\"I don't think there's the slightest chance that Warren Buffett is doing something that's deeply evil to make money for himself,\" said the 99-year-old vice-chairman of Buffett's Berkshire Hathaway conglomerate.",
            "banner_image": "https://ocdn.eu/pulscms-transforms/1/thYktkuTURBXy8zYjM1NjIzZi1lZGIxLTQyNDMtODUxZS1iMTlkNjQ3Zjc1OWUuanBlZ5GTBc0DFs0Brg",
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "africa.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.094709,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "WFC",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "-0.111994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "-0.103755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "-0.111994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.146025",
                    "ticker_sentiment_score": "-0.111994",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Charlie Munger blasts 'ridiculous' idea that Warren Buffett enriched himself at his shareholders' expense",
            "url": "https://markets.businessinsider.com/news/stocks/charlie-munger-warren-buffett-propublica-personal-stock-portfolio-berkshire-trades-2023-11",
            "time_published": "20231116T170600",
            "authors": [
                "Theron Mohamed"
            ],
            "summary": "Munger Blasts Idea Buffett Enriched Himself Over Berkshire Shareholders - Markets Insider ...",
            "banner_image": null,
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "markets.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.132179,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "WFC",
                    "relevance_score": "0.105141",
                    "ticker_sentiment_score": "-0.095301",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.208464",
                    "ticker_sentiment_score": "0.106194",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.105141",
                    "ticker_sentiment_score": "-0.095301",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.105141",
                    "ticker_sentiment_score": "-0.095301",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "No chance Warren Buffett is doing something 'deeply evil,' says Charlie Munger",
            "url": "https://www.marketwatch.com/story/no-chance-warren-buffett-is-doing-something-deeply-evil-says-charlie-munger-8803fd52",
            "time_published": "20231116T164900",
            "authors": [
                "Weston Blasi"
            ],
            "summary": "Buffett reportedly traded stocks that Berkshire Hathaway was buying and selling, according to a recent ProPublica story ...",
            "banner_image": "https://images.mktw.net/im-426442/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.02853,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "WFC",
                    "relevance_score": "0.113597",
                    "ticker_sentiment_score": "-0.038609",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.524949",
                    "ticker_sentiment_score": "-0.103829",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.113597",
                    "ticker_sentiment_score": "-0.038609",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.113597",
                    "ticker_sentiment_score": "-0.038609",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  Down 2.6% Since Last Earnings Report: Can It Rebound?",
            "url": "https://www.zacks.com/stock/news/2185490/johnson-johnson-jnj-down-26-since-last-earnings-report-can-it-rebound",
            "time_published": "20231116T163009",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default101.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999994"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.87644"
                }
            ],
            "overall_sentiment_score": 0.227036,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.02607",
                    "ticker_sentiment_score": "0.178187",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AWON",
                    "relevance_score": "0.02607",
                    "ticker_sentiment_score": "0.028362",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.104002",
                    "ticker_sentiment_score": "0.046419",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.02607",
                    "ticker_sentiment_score": "0.028362",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Better Being announces leadership transition for next phase of growth - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/better-being-announces-leadership-transition-for-next-phase-of-growth-301990736.html",
            "time_published": "20231116T150000",
            "authors": [],
            "summary": "Better Being announces leadership transition for next phase of growth PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                }
            ],
            "overall_sentiment_score": 0.537085,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.051111",
                    "ticker_sentiment_score": "0.149949",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.051111",
                    "ticker_sentiment_score": "0.1204",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Digital Health Market is Expected to Reach $549.7 billion | MarketsandMarkets.",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35824455/digital-health-market-is-expected-to-reach-549-7-billion-marketsandmarkets",
            "time_published": "20231116T123000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Chicago, Nov. 16, 2023 ( GLOBE NEWSWIRE ) -- Digital Health market in terms of revenue was estimated to be worth $180.2 billion in 2023 and is poised to reach $549.7 billion by 2028, growing at a CAGR of 25.0% from 2023 to 2028 according to a latest report published by MarketsandMarkets™.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.249454,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "-0.0347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMRNF",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "-0.0347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "-0.0347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TDOC",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "-0.0347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BTCY",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "-0.0347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "-0.0347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDRX",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "-0.0347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SEMHF",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "-0.0347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.080865",
                    "ticker_sentiment_score": "0.026583",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "-0.0347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PHG",
                    "relevance_score": "0.040484",
                    "ticker_sentiment_score": "-0.0347",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B - Sanofi  ( NASDAQ:SNY ) ",
            "url": "https://www.benzinga.com/markets/equities/23/11/35823034/major-buyout-firms-eye-sanofis-consumer-health-division-spinoff-valued-over-20b",
            "time_published": "20231116T115811",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Sanofi SA SNY has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at over $20 billion.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/16/sny.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Mergers",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.242568,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.297661",
                    "ticker_sentiment_score": "-0.170933",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "PIEJF",
                    "relevance_score": "0.151539",
                    "ticker_sentiment_score": "0.096913",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HLN",
                    "relevance_score": "0.297661",
                    "ticker_sentiment_score": "-0.170933",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "GSK",
                    "relevance_score": "0.297661",
                    "ticker_sentiment_score": "-0.170933",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.297661",
                    "ticker_sentiment_score": "-0.170933",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.818966",
                    "ticker_sentiment_score": "0.405237",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On",
            "url": "https://www.fool.com/investing/2023/11/16/looking-for-stocks-to-buy-heres-who-johnson-johnso/",
            "time_published": "20231116T105000",
            "authors": [
                "Keith Speights"
            ],
            "summary": "Unsurprisingly, Johnson & Johnson's top investments are all in the healthcare sector.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.18793,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PTGX",
                    "relevance_score": "0.162073",
                    "ticker_sentiment_score": "0.117149",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LEGN",
                    "relevance_score": "0.266828",
                    "ticker_sentiment_score": "0.117951",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVRX",
                    "relevance_score": "0.366832",
                    "ticker_sentiment_score": "0.208509",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.460544",
                    "ticker_sentiment_score": "0.159224",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow.",
            "url": "https://www.barrons.com/articles/eli-lilly-pfizer-astrazeneca-drug-pharma-stocks-de1d4c9d",
            "time_published": "20231116T070000",
            "authors": [
                "Josh Nathan-Kazis"
            ],
            "summary": "Most drug stocks have been out of favor in 2023. Pfizer was down 43.4% as of the market close Monday, while Johnson & Johnson is down 16.4%. Despite Eli Lilly's monster 66.8% gain on the year, amid investor frenzy over its weight-loss drugs, the S&P 500 Pharmaceuticals index is down 2.3%.",
            "banner_image": "https://images.barrons.com/im-55106931/social",
            "source": "Barrons",
            "category_within_source": "n/a",
            "source_domain": "www.barrons.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.263257,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PFE",
                    "relevance_score": "0.716023",
                    "ticker_sentiment_score": "0.410039",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.716023",
                    "ticker_sentiment_score": "0.410039",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Berkshire sheds GM, Johnson & Johnson, Procter & Gamble as it amasses cash",
            "url": "https://www.foxbusiness.com/markets/berkshire-sheds-gm-johnson-johnson-procter-gamble-amasses-cash",
            "time_published": "20231116T002500",
            "authors": [
                "Reuters"
            ],
            "summary": "Berkshire Hathaway said it has shed its holdings in General Motors, Johnson & Johnson and Procter & Gamble, and trimmed its stake in Amazon.com, as the conglomerate controlled by Warren Buffett boosted its cash pile to a record $157.2 billion.",
            "banner_image": "https://cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/8357ecb4-105b-473e-bcd4-89d048a00545/0f4b9f0e-82de-4991-b9bb-e23130350cd1/1280x720/match/image.jpg",
            "source": "Fox Business News",
            "category_within_source": "n/a",
            "source_domain": "www.foxbusiness.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99977"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.093731,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AON",
                    "relevance_score": "0.077593",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.077593",
                    "ticker_sentiment_score": "-0.041957",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BATRA",
                    "relevance_score": "0.077593",
                    "ticker_sentiment_score": "0.089125",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GL",
                    "relevance_score": "0.077593",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.154455",
                    "ticker_sentiment_score": "0.052452",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.154455",
                    "ticker_sentiment_score": "0.151253",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.077593",
                    "ticker_sentiment_score": "0.070857",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.077593",
                    "ticker_sentiment_score": "0.272825",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MKL",
                    "relevance_score": "0.077593",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.077593",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.077593",
                    "ticker_sentiment_score": "0.070857",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.077593",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UPS",
                    "relevance_score": "0.077593",
                    "ticker_sentiment_score": "-0.041957",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Warren Buffett's Berkshire Hathaway sold all of its GM stock | Business",
            "url": "https://www.cnn.com/2023/11/15/investing/warren-buffett-berkshire-hathaway-gm-stock/index.html",
            "time_published": "20231115T213500",
            "authors": [
                "Nicole Goodkind"
            ],
            "summary": "Warren Buffett's Berkshire Hathaway sold all of its GM stock ...",
            "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/230803094932-02-warren-buffett-0503-file.jpg?c=16x9&q=h_144,w_256,c_fill",
            "source": "CNN",
            "category_within_source": "Markets",
            "source_domain": "www.cnn.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.986714"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.193417,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.080458",
                    "ticker_sentiment_score": "0.067083",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SIRI",
                    "relevance_score": "0.080458",
                    "ticker_sentiment_score": "0.220622",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.238133",
                    "ticker_sentiment_score": "0.096795",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.520477",
                    "ticker_sentiment_score": "0.300372",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.080458",
                    "ticker_sentiment_score": "0.067083",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.080458",
                    "ticker_sentiment_score": "0.067083",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "JNJ: Analyzing Pharma Stock Giants: JNJ, MRK, and ABBV",
            "url": "https://stocknews.com/news/jnj-mrk-abbv-kvue-analyzing-pharma-stock-giants-jnj-mrk-and-abbv/",
            "time_published": "20231115T163013",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "JNJ: Analyzing Pharma Stock Giants: JNJ, MRK, and ...",
            "banner_image": "https://stocknews.com/wp-content/uploads/2023/07/ABhuyan.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999996"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.996023"
                }
            ],
            "overall_sentiment_score": 0.233975,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.204072",
                    "ticker_sentiment_score": "0.142349",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NXGL",
                    "relevance_score": "0.029472",
                    "ticker_sentiment_score": "0.157367",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "RXDX",
                    "relevance_score": "0.029472",
                    "ticker_sentiment_score": "0.074984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.204072",
                    "ticker_sentiment_score": "0.124423",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Dividend Stocks Near Their 52-Week Lows to Buy and Hold Forever",
            "url": "https://www.fool.com/investing/2023/11/15/2-dividend-stocks-near-their-52-week-lows-to-buy-a/",
            "time_published": "20231115T150700",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "These longtime healthcare leaders have faced -- and overcome -- plenty of obstacles before.",
            "banner_image": "https://media.ycharts.com/charts/5e05e445faa9844a5a33e747b08e1f16.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.265609,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CVS",
                    "relevance_score": "0.588384",
                    "ticker_sentiment_score": "0.31828",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.386626",
                    "ticker_sentiment_score": "0.323064",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Investors Heavily Search Johnson & Johnson  ( JNJ ) : Here is What You Need to Know",
            "url": "https://www.zacks.com/stock/news/2184526/investors-heavily-search-johnson-johnson-jnj-here-is-what-you-need-to-know",
            "time_published": "20231115T140009",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default65.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.503496"
                }
            ],
            "overall_sentiment_score": 0.229152,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.477606",
                    "ticker_sentiment_score": "0.106521",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Alcon stock falls as third-quarter sales miss estimates",
            "url": "https://www.marketwatch.com/story/alcons-stock-falls-as-third-quarter-sales-miss-estimates-96cebc74",
            "time_published": "20231115T134900",
            "authors": [
                "Eleanor Laise"
            ],
            "summary": "Eye care company reins in full-year sales and profit outlook ...",
            "banner_image": "https://images.mktw.net/im-89320276/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.983605"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.213936,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ALC",
                    "relevance_score": "0.736438",
                    "ticker_sentiment_score": "0.331586",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BLCO",
                    "relevance_score": "0.290607",
                    "ticker_sentiment_score": "0.154617",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.290607",
                    "ticker_sentiment_score": "0.154617",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Noema Pharma Appoints Robert Lasser, M.D., as Chief Medical Officer",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35802163/noema-pharma-appoints-robert-lasser-m-d-as-chief-medical-officer",
            "time_published": "20231115T130000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "BASEL, Switzerland, Nov. 15, 2023 ( GLOBE NEWSWIRE ) -- Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system ( CNS ) disorders, today announced Robert Lasser, M.D., M.B.A has joined the Company as Chief Medical Officer ( CMO ) .",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.04065,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SAGE",
                    "relevance_score": "0.066598",
                    "ticker_sentiment_score": "-0.006014",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.066598",
                    "ticker_sentiment_score": "-0.006014",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Warren Buffett's Berkshire Hathaway sheds investments in GM, J&J and P&G",
            "url": "https://www.fnlondon.com/articles/warren-buffetts-berkshire-hathaway-sheds-investments-in-gm-jj-and-pg-20231115",
            "time_published": "20231115T105600",
            "authors": [
                "the Wall Street Journal",
                "Karen Langley"
            ],
            "summary": "Warren Buffett's Berkshire Hathaway eliminated its stake in a handful of American blue chips, including General Motors and Johnson & Johnson, while the stock market's rally sputtered in the third quarter.",
            "banner_image": "https://images.fnlondon.com/im-887304/?width=700&height=466",
            "source": "Financial News London",
            "category_within_source": "n/a",
            "source_domain": "www.fnlondon.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.0,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.546745",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UPS",
                    "relevance_score": "0.546745",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.546745",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.546745",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.546745",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.546745",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Moves to Make if the Stock Market Plummets Tomorrow",
            "url": "https://www.fool.com/investing/2023/11/15/3-moves-to-make-if-the-stock-market-plummets/",
            "time_published": "20231115T103000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "These steps could boost your long-term performance.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F755036%2Fgettyimages-1316264191.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.064078,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.111488",
                    "ticker_sentiment_score": "0.07066",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.111488",
                    "ticker_sentiment_score": "0.07066",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.111488",
                    "ticker_sentiment_score": "0.07066",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.111488",
                    "ticker_sentiment_score": "0.07066",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Warren Buffett's Berkshire Hathaway reveals it sold a bunch of long-held stocks - and made at least one secret bet",
            "url": "https://markets.businessinsider.com/news/stocks/warren-buffett-berkshire-hathaway-secret-stock-sales-gm-q3-portfolio-2023-11",
            "time_published": "20231115T095500",
            "authors": [
                "Theron Mohamed"
            ],
            "summary": "Buffett's Berkshire Sold Long-Held Stocks, Made Secret Bet: Q3 Update - Markets Insider ...",
            "banner_image": null,
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "markets.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.026226,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.229149",
                    "ticker_sentiment_score": "0.147785",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BATRA",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.290811",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.012766",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GL",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.290811",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.439786",
                    "ticker_sentiment_score": "-0.017849",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "-0.086936",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.095902",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.095902",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Buffett's Berkshire Trimmed Chevron Stake While Cashing Out Of GM And This COVID Stock: Here's How The Sage Of Omaha Adjusted His Portfolio In Q3 - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ",
            "url": "https://www.benzinga.com/markets/equities/23/11/35797715/buffetts-berkshire-trimmed-chevron-stake-while-cashing-out-of-gm-and-this-covid-stock-heres-how-",
            "time_published": "20231115T074753",
            "authors": [
                "Shanthi Rexaline"
            ],
            "summary": "Billionaire investor Warren Buffett-run Berkshire Hathaway, Inc. BRK BRK maintained its core portfolio stocks largely unchanged in the third quarter but divested a slew of stocks including legacy automaker General Motors Corp. GM.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Warren-Buffett--Chairman-And-Ceo-Of-Berk.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.142857"
                }
            ],
            "overall_sentiment_score": 0.189995,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.225425",
                    "ticker_sentiment_score": "0.183019",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.125406",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BATRA",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.17127",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CVX",
                    "relevance_score": "0.225425",
                    "ticker_sentiment_score": "0.374193",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.125406",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNOW",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.170075",
                    "ticker_sentiment_score": "0.080972",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.107548",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KR",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.141052",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SIRI",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.353805",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.152238",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "OXY",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.17015",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LEN",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MA",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.107548",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.125406",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UPS",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.107548",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COF",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.087492",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRSN",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Warren Buffett's Berkshire Hathaway Sheds Investments in GM, J&J and P&G",
            "url": "https://www.wsj.com/finance/stocks/warren-buffetts-berkshire-hathaway-sheds-investments-in-gm-j-j-and-p-g-5529f8f5",
            "time_published": "20231115T025100",
            "authors": [
                "Karen Langley"
            ],
            "summary": "Berkshire's stock portfolio is concentrated in five companies: Apple, Bank of America, American Express, Coca-Cola and Chevron.",
            "banner_image": "https://images.wsj.net/im-886400?width=700&height=466",
            "source": "Wall Street Journal",
            "category_within_source": "Markets",
            "source_domain": "www.wsj.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.0,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.535653",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UPS",
                    "relevance_score": "0.535653",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.535653",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.535653",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.535653",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.535653",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why a derailed $11 trillion corporate bond market looks ripe for a comeback as U.S. inflation slows",
            "url": "https://www.marketwatch.com/story/why-a-derailed-11-trillion-corporate-bond-market-looks-ripe-for-a-comeback-as-u-s-inflation-slows-a682a46c",
            "time_published": "20231114T211700",
            "authors": [
                "Joy Wiltermuth"
            ],
            "summary": "Bonds issued by America's most valuable companies are steaming ahead after sinking to their lowest prices in about 20 years.",
            "banner_image": "https://images.mktw.net/im-886913?width=700&height=394",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999995"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": -0.067659,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.008397",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.008397",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AWON",
                    "relevance_score": "0.060694",
                    "ticker_sentiment_score": "-0.041",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.121037",
                    "ticker_sentiment_score": "0.008397",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Medical Component Manufacturing Market Analysis 2023-2027: Estimated Market Size, Key Drivers And Lucrative Segments As Per The Business Research Company's Medical Component Manufacturing Global Market Report 2023",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35781916/medical-component-manufacturing-market-analysis-2023-2027-estimated-market-size-key-drivers-and-lu",
            "time_published": "20231114T163000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "LONDON, Nov. 14, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's Medical Component Manufacturing Global Market Report 2023 unveils a robust trajectory, forecasting growth from $12.44 billion in 2022 to $13.29 billion in 2023, reflecting a commendable compound annual growth rate ( CAGR ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.294287,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ABT",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.211882",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SEMHF",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.211882",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.211882",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SSYS",
                    "relevance_score": "0.108466",
                    "ticker_sentiment_score": "0.223411",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.054359",
                    "ticker_sentiment_score": "0.211882",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Dow Gains 500 Points On Cooling Inflation; Tesla Rises On China Price Hikes",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-gains-500-points-on-cooling-inflation-tesla-rises-on-china-price-hikes/",
            "time_published": "20231114T162100",
            "authors": [
                "VIDYA RAMAKRISHNAN",
                "Investor's Business Daily"
            ],
            "summary": "Dow Gains 500 Points On Cooling Inflation. Tesla Rises On China ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2021/01/Stock-Tesla-modelY-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999819"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.795202"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.069537,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.090134",
                    "ticker_sentiment_score": "-0.029969",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.090134",
                    "ticker_sentiment_score": "0.176793",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FSR",
                    "relevance_score": "0.090134",
                    "ticker_sentiment_score": "0.024468",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTU",
                    "relevance_score": "0.134841",
                    "ticker_sentiment_score": "0.157393",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SMCI",
                    "relevance_score": "0.090134",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.090134",
                    "ticker_sentiment_score": "-0.058687",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TOL",
                    "relevance_score": "0.134841",
                    "ticker_sentiment_score": "-0.020753",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MELI",
                    "relevance_score": "0.090134",
                    "ticker_sentiment_score": "0.161096",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.134841",
                    "ticker_sentiment_score": "0.005003",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FIX",
                    "relevance_score": "0.090134",
                    "ticker_sentiment_score": "0.134875",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVNA",
                    "relevance_score": "0.090134",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HD",
                    "relevance_score": "0.090134",
                    "ticker_sentiment_score": "0.027914",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.179121",
                    "ticker_sentiment_score": "-0.041177",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, J&J and AbbVie",
            "url": "https://www.zacks.com/stock/news/2183791/zacks-industry-outlook-highlights-eli-lilly-novo-nordisk-jj-and-abbvie",
            "time_published": "20231114T124200",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Eli Lilly, Novo Nordisk, J&J and AbbVie are part of the Zacks Industry Outlook article.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ff/2922.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.996023"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.976913"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.17517,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.023556",
                    "ticker_sentiment_score": "-0.021479",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.140621",
                    "ticker_sentiment_score": "0.116722",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.047092",
                    "ticker_sentiment_score": "0.030471",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.047092",
                    "ticker_sentiment_score": "0.060093",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.16375",
                    "ticker_sentiment_score": "0.056556",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.16375",
                    "ticker_sentiment_score": "0.136116",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SGEN",
                    "relevance_score": "0.023556",
                    "ticker_sentiment_score": "0.11584",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.023556",
                    "ticker_sentiment_score": "0.11584",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki  ( AVT04 ) , the First Biosimilar of Stelara®  ( ustekinumab ) ",
            "url": "https://www.globenewswire.com/news-release/2023/11/14/2779894/0/en/Alvotech-and-JAMP-Pharma-Announce-Receipt-of-Marketing-Authorization-for-Jamteki-AVT04-the-First-Biosimilar-of-Stelara-ustekinumab.html",
            "time_published": "20231114T120000",
            "authors": [
                "Alvotech"
            ],
            "summary": "Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and JAMP Pharma Group ( \"JAMP Pharma\" ) , a Canadian owned pharmaceutical organization headquartered in the Greater Montreal area, announced today ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.164027,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ALVO",
                    "relevance_score": "0.487178",
                    "ticker_sentiment_score": "0.191722",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.020885",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.020885",
                    "ticker_sentiment_score": "0.057625",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMDA",
                    "relevance_score": "0.020885",
                    "ticker_sentiment_score": "0.057625",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LTUS",
                    "relevance_score": "0.020885",
                    "ticker_sentiment_score": "0.057625",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.020885",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki™  ( AVT04 ) , the First Biosimilar of Stelara®  ( ustekinumab ) ",
            "url": "https://www.globenewswire.com/news-release/2023/11/14/2779896/0/en/Alvotech-and-JAMP-Pharma-Announce-Receipt-of-Marketing-Authorization-for-Jamteki-AVT04-the-First-Biosimilar-of-Stelara-ustekinumab.html",
            "time_published": "20231114T120000",
            "authors": [
                "Alvotech"
            ],
            "summary": "PrJamtekiTM is the second biosimilar developed under this partnership that receives marketing authorization in Canada.",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/17a8091d-68a6-47c1-968e-fcced99f1d44",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.164016,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ALVO",
                    "relevance_score": "0.484252",
                    "ticker_sentiment_score": "0.190966",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.02074",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.02074",
                    "ticker_sentiment_score": "0.05757",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMDA",
                    "relevance_score": "0.02074",
                    "ticker_sentiment_score": "0.05757",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LTUS",
                    "relevance_score": "0.02074",
                    "ticker_sentiment_score": "0.05757",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.02074",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Alvotech and JAMP Pharma announce receipt of marketing authorization for PrJamtekiTM (AVT04), the first biosimilar ... - Canada NewsWire",
            "url": "https://www.newswire.ca/news-releases/alvotech-and-jamp-pharma-announce-receipt-of-marketing-authorization-for-prjamtekitm-avt04-the-first-biosimilar-of-stelara-r-ustekinumab--858287722.html",
            "time_published": "20231114T120000",
            "authors": [],
            "summary": "Alvotech and JAMP Pharma announce receipt of marketing authorization for PrJamtekiTM ( AVT04 ) , the first biosimilar ... Canada ...",
            "banner_image": null,
            "source": "Canada Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.newswire.ca",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.161521,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ALVO",
                    "relevance_score": "0.497575",
                    "ticker_sentiment_score": "0.187743",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.020579",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.020579",
                    "ticker_sentiment_score": "0.04932",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KMDA",
                    "relevance_score": "0.020579",
                    "ticker_sentiment_score": "0.04932",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LTUS",
                    "relevance_score": "0.020579",
                    "ticker_sentiment_score": "0.04932",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.020579",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing",
            "url": "https://www.fool.com/investing/2023/11/14/3-dividend-giants-to-grow-wealth-in-any-market/",
            "time_published": "20231114T103000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "You'll be happy to own these top companies in any market environment.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F754885%2Fgettyimages-1197547531.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.996023"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.857896"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.37175,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.300946",
                    "ticker_sentiment_score": "0.233919",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.061631",
                    "ticker_sentiment_score": "0.080007",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.24289",
                    "ticker_sentiment_score": "0.336641",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.122894",
                    "ticker_sentiment_score": "0.290972",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients",
            "url": "https://www.globenewswire.com/news-release/2023/11/14/2779698/0/en/Addex-ADX71149-Epilepsy-Phase-2-Study-Completes-Recruitment-of-Patients.html",
            "time_published": "20231114T060000",
            "authors": [
                "Addex Therapeutics"
            ],
            "summary": "Ad Hoc Announcement Pursuant to Art. 53 LR ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/e6c12443-4244-46f9-909c-5ab241bbea41",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.184653,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "INDV",
                    "relevance_score": "0.036037",
                    "ticker_sentiment_score": "0.047811",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADXN",
                    "relevance_score": "0.282234",
                    "ticker_sentiment_score": "0.083903",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.072",
                    "ticker_sentiment_score": "0.083491",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "DRI Healthcare Trust Reports Third Quarter 2023 Results",
            "url": "https://www.newswire.ca/news-releases/dri-healthcare-trust-reports-third-quarter-2023-results-855892981.html",
            "time_published": "20231113T220000",
            "authors": [
                "DRI Healthcare Trust"
            ],
            "summary": "- 36% royalty income growth over prior year period highlights successful portfolio growth strategy - - Significant deployment capacity available after follow-on offerings and credit facility increase -",
            "banner_image": "https://mma.prnewswire.com/media/2275167/DRI_Healthcare_Trust_DRI_Healthcare_Trust_Reports_Third_Quarter.jpg?p=facebook",
            "source": "Canada Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.newswire.ca",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999894"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.303847,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CURN",
                    "relevance_score": "0.011005",
                    "ticker_sentiment_score": "0.059424",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.011005",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "NANOBIOTIX Provides Third Quarter 2023 Operational and Financial Update",
            "url": "https://www.globenewswire.com/news-release/2023/11/13/2779491/0/en/NANOBIOTIX-Provides-Third-Quarter-2023-Operational-and-Financial-Update.html",
            "time_published": "20231113T211500",
            "authors": [
                "Nanobiotix S.A."
            ],
            "summary": "Conference call and webcast scheduled for Tuesday, November 14, 2023, at 2:00 pm CET / 8:00 am ET ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/36fb7b98-27d7-46cb-b989-fa31626657b8",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.990999"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.104657,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NBTX",
                    "relevance_score": "0.221481",
                    "ticker_sentiment_score": "0.065753",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.056055",
                    "ticker_sentiment_score": "0.086984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:NANO",
                    "relevance_score": "0.018699",
                    "ticker_sentiment_score": "0.011747",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Pfizer Stock Hits 3-Year Low-Down 50% From 2021 Peak",
            "url": "https://www.forbes.com/sites/dereksaul/2023/11/13/pfizer-stock-hits-3-year-low-down-50-from-2021-peak/",
            "time_published": "20231113T210853",
            "authors": [
                "Derek Saul"
            ],
            "summary": "Pfizer shares tumbled again Monday, continuing the pharmaceutical giant's struggles tied to declining demand for its Covid-19 products and essentially wiping out the entirety of the firm's peak pandemic gains. Pfizer stock slipped 1.6% to $28.96, closing at its lowest share price since March 26, ...",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/65528ed147e90d7670350551/0x0.jpg?format=jpg&crop=4000,2250,x0,y186,safe&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                }
            ],
            "overall_sentiment_score": -0.019531,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.110462",
                    "ticker_sentiment_score": "-0.007782",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.218817",
                    "ticker_sentiment_score": "0.193129",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.733479",
                    "ticker_sentiment_score": "-0.031645",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BNTX",
                    "relevance_score": "0.110462",
                    "ticker_sentiment_score": "-0.007782",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.110462",
                    "ticker_sentiment_score": "-0.007782",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Asset manager GMO's first ETF will focus on 'quality' companies",
            "url": "https://www.reuters.com/business/finance/asset-manager-gmos-first-etf-will-focus-quality-companies-2023-11-13/",
            "time_published": "20231113T200100",
            "authors": [
                "Suzanne McGee"
            ],
            "summary": "Jeremy Grantham, co-founder and chief investment strategist of GMO, takes notes during an Oxford-style debate on financial innovation hosted by \"The Economist\" magazine at Pace University in New York October 16, 2009. REUTERS/Nicholas Roberts/File Photo Acquire Licensing Rights",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/UBRBU27S2RLOJE2YSIWIKBMREE.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.994953"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.238959,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GS",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "0.060868",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "0.273544",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "0.273544",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Investors seeking triple-A rated U.S. corporate debt only have these two choices - for now",
            "url": "https://www.marketwatch.com/story/investors-seeking-triple-a-rated-u-s-corporate-debt-only-have-these-two-choices-for-now-f2c4f9f6",
            "time_published": "20231113T162400",
            "authors": [
                "Ciara Linnane"
            ],
            "summary": "If Moody's downgrades the U.S. rating, it may not bode well for the two remaining triple-A corporate credits.",
            "banner_image": "https://images.mktw.net/im-886089?width=700&height=436",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.024109,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MCO",
                    "relevance_score": "0.351807",
                    "ticker_sentiment_score": "-0.09993",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.575407",
                    "ticker_sentiment_score": "-0.124094",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.090816",
                    "ticker_sentiment_score": "-0.081975",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.18046",
                    "ticker_sentiment_score": "0.125617",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35755047/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc-kvue",
            "time_published": "20231113T162015",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "NEW YORK, Nov. 13, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( \"Kenvue\" or the \"Company\" ) KVUE. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                }
            ],
            "overall_sentiment_score": 0.021762,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.691995",
                    "ticker_sentiment_score": "0.011422",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.021477",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "4 Large Drug Stocks Likely to Sail Through Industry Woes",
            "url": "https://www.zacks.com/commentary/2183148/4-large-drug-stocks-likely-to-sail-through-industry-woes",
            "time_published": "20231113T150300",
            "authors": [
                "Kinjel Shah"
            ],
            "summary": "Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), J&J (JNJ) and AbbVie (ABBV) are worth retaining in your portfolio.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/b2/19786.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.986564"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.179759,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.024546",
                    "ticker_sentiment_score": "0.067704",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.097954",
                    "ticker_sentiment_score": "0.099631",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.04907",
                    "ticker_sentiment_score": "0.092705",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.04907",
                    "ticker_sentiment_score": "0.102773",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.146469",
                    "ticker_sentiment_score": "0.118959",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "0.108175",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SGEN",
                    "relevance_score": "0.024546",
                    "ticker_sentiment_score": "0.067704",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.024546",
                    "ticker_sentiment_score": "0.067704",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "KENVUE INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/kenvue-investor-deadline-approaching-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301985405.html",
            "time_published": "20231113T134500",
            "authors": [],
            "summary": "KENVUE INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James ( Josh ) Wilson Encourages ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.16377,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.600121",
                    "ticker_sentiment_score": "0.021496",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCLI",
                    "relevance_score": "0.061003",
                    "ticker_sentiment_score": "0.219133",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DOCN",
                    "relevance_score": "0.061003",
                    "ticker_sentiment_score": "0.219133",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.061003",
                    "ticker_sentiment_score": "0.093005",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Comera Life Sciences Appoints Dorothy Clarke to Board of Directors - Comera Life Sciences  ( NASDAQ:CMRA ) ",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35746556/comera-life-sciences-appoints-dorothy-clarke-to-board-of-directors",
            "time_published": "20231113T130019",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "WOBURN, Mass., Nov. 13, 2023 ( GLOBE NEWSWIRE ) -- Comera Life Sciences Holdings, Inc. CMRA, a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced it appointed Dorothy Clarke to its board of directors.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.150475,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CMRA",
                    "relevance_score": "0.208017",
                    "ticker_sentiment_score": "0.268856",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.05257",
                    "ticker_sentiment_score": "0.058687",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Comera Life Sciences Appoints Dorothy Clarke to Board of Directors",
            "url": "https://www.globenewswire.com/news-release/2023/11/13/2779029/0/en/Comera-Life-Sciences-Appoints-Dorothy-Clarke-to-Board-of-Directors.html",
            "time_published": "20231113T130000",
            "authors": [
                "Comera Life Sciences"
            ],
            "summary": "WOBURN, Mass., Nov. 13, 2023 ( GLOBE NEWSWIRE ) -- Comera Life Sciences Holdings, Inc. ( Nasdaq: CMRA ) , a life sciences company developing a new generation of biologic medicines to improve patient access, safety, and convenience, today announced it appointed Dorothy Clarke to its board of ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/da9a654c-f20c-4060-abad-db5b2b124a44",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.152978,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CMRA",
                    "relevance_score": "0.211652",
                    "ticker_sentiment_score": "0.283502",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.053509",
                    "ticker_sentiment_score": "0.058756",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the Vanguard Health Care ETF  ( VHT ) ?",
            "url": "https://www.zacks.com/stock/news/2183064/should-you-invest-in-the-vanguard-health-care-etf-vht",
            "time_published": "20231113T112005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default15.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.244101,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.064321",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "0.125774",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.064321",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.064321",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Better Buy Now: Novo Nordisk vs. Eli Lilly",
            "url": "https://www.fool.com/investing/2023/11/13/better-buy-now-novo-nordisk-vs-eli-lilly/",
            "time_published": "20231113T111700",
            "authors": [
                "Cory Renauer"
            ],
            "summary": "Both of these companies are reporting positive news for their competing weight-loss drugs, but which is the better stock to buy now?",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F754828%2Finvestors-evaluating-a-stock-purchase-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.18026,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.26928",
                    "ticker_sentiment_score": "0.145472",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.22574",
                    "ticker_sentiment_score": "0.2449",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.045743",
                    "ticker_sentiment_score": "0.029926",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.045743",
                    "ticker_sentiment_score": "0.029926",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Sports medicine market size to grow by USD 2.64 billion from 2022 to 2027|The increasing incidence of sports injuries ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/sports-medicine-market-size-to-grow-by-usd-2-64-billion-from-2022-to-2027the-increasing-incidence-of-sports-injuries-drives-the-market-growth---technavio-301984318.html",
            "time_published": "20231113T033500",
            "authors": [],
            "summary": "Sports medicine market size to grow by USD 2.64 billion from 2022 to 2027|The increasing incidence of sports injuries ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.108505,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.056143",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.056143",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.056143",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.056143",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.056143",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.056143",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNMD",
                    "relevance_score": "0.056143",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OSSFF",
                    "relevance_score": "0.056143",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "KVUE ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Kenvue Inc.  ( KVUE )  Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35740511/kvue-alert-kessler-topaz-meltzer-check-llp-reminds-kenvue-inc-kvue-shareholders-of-securities-frau",
            "time_published": "20231112T155900",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "RADNOR, Pa., Nov. 12, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Kenvue Inc. ( \"Kenvue\" ) KVUE. ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": 0.096899,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.526003",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.129961",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE",
            "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc---kvue-301985117.html",
            "time_published": "20231111T151000",
            "authors": [
                "Pomerantz LLP"
            ],
            "summary": "NEW YORK, Nov. 11, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( \"Kenvue\" or the \"Company\" ) ( NYSE: KVUE ) . Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.",
            "banner_image": "https://mma.prnewswire.com/media/1486339/Pomerantz_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                }
            ],
            "overall_sentiment_score": 0.053268,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.725935",
                    "ticker_sentiment_score": "0.070022",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.124164",
                    "ticker_sentiment_score": "0.023342",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Cautious Investor? 2 Safe Stocks You Also Can Count on For Growth",
            "url": "https://www.fool.com/investing/2023/11/11/cautious-investor-2-safe-stocks-you-also-can-count/",
            "time_published": "20231111T100000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "These stocks offer the best of both worlds.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F754495%2Fgettyimages-1253877215.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.98396"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.44085,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.2842",
                    "ticker_sentiment_score": "0.355549",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "DICE",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "-0.059248",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.207342",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Big Players' Recent Trades in JNJ Options - Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/markets/options/23/11/35729474/big-players-recent-trades-in-jnj-options",
            "time_published": "20231110T164737",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Whales with a lot of money to spend have taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson JNJ we detected 10 trades. If we consider the specifics of each trade, it is accurate to state that 70% of the investors opened trades with bullish ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.159026,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.072",
                    "ticker_sentiment_score": "0.139991",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.072",
                    "ticker_sentiment_score": "0.095587",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.072",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.679765",
                    "ticker_sentiment_score": "0.363878",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Warren Buffett's followers just got a rare peek inside his personal stock portfolio. Here's what they learned from a new report.",
            "url": "https://markets.businessinsider.com/news/stocks/warren-buffett-personal-portfolio-stocks-size-berkshire-hathaway-propublica-billionaires-2023-11",
            "time_published": "20231110T161000",
            "authors": [
                "Theron Mohamed"
            ],
            "summary": "Warren Buffett's Personal Portfolio: New Report Hints at Size, Stocks - Markets Insider ...",
            "banner_image": null,
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "markets.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.503496"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.085194,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "WFC",
                    "relevance_score": "0.32478",
                    "ticker_sentiment_score": "0.067899",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.111644",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.025227",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.32478",
                    "ticker_sentiment_score": "0.016468",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Top Biotech Stocks to Buy Right Now",
            "url": "https://www.fool.com/investing/2023/11/10/2-top-biotech-stocks-to-buy-right-now/",
            "time_published": "20231110T151500",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "Don't give up on these stocks too fast.",
            "banner_image": "https://media.ycharts.com/charts/23bb3db224d5e90f0f2ad5eb3a2c68b0.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.891286"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                }
            ],
            "overall_sentiment_score": 0.186111,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.380426",
                    "ticker_sentiment_score": "0.253569",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.521812",
                    "ticker_sentiment_score": "0.388976",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.05654",
                    "ticker_sentiment_score": "0.084917",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research",
            "url": "https://www.prnewswire.com/news-releases/oncology-drugs-market-worth-520-billion-by-2033---exclusive-report-by-we-market-research-301984776.html",
            "time_published": "20231110T150100",
            "authors": [
                "We Market Research"
            ],
            "summary": "CHICAGO, Nov. 10, 2023 /PRNewswire/ -- According to the latest findings from We Market Research, the oncology drug market is on track to achieve a value of USD 205 billion by the year 2023.",
            "banner_image": "https://mma.prnewswire.com/media/2267296/We_Market_Research_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.227297,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.040622",
                    "ticker_sentiment_score": "0.059987",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.040622",
                    "ticker_sentiment_score": "0.059987",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALPMF",
                    "relevance_score": "0.040622",
                    "ticker_sentiment_score": "0.059987",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.081138",
                    "ticker_sentiment_score": "0.083483",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SGEN",
                    "relevance_score": "0.040622",
                    "ticker_sentiment_score": "0.029936",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.040622",
                    "ticker_sentiment_score": "0.059987",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.081138",
                    "ticker_sentiment_score": "0.046543",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.040622",
                    "ticker_sentiment_score": "0.059987",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Baby Diaper Market is Estimated to Attain a Size of $73Bn Globally by 2030 - Exclusive Report by The Insight Partners",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35725140/baby-diaper-market-is-estimated-to-attain-a-size-of-73bn-globally-by-2030-exclusive-report-by-the-",
            "time_published": "20231110T140602",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Pune, India, Nov. 10, 2023 ( GLOBE NEWSWIRE ) -- According to our latest study on \"Baby Diaper Market Size Report, Forecast to 2030 - COVID-19 Impact and Global Analysis - by Type, Distribution Channel, and Geography,\" the baby diaper market is expected to grow from $47 billion in 2022 to $73 ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.25398,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SHOP",
                    "relevance_score": "0.02689",
                    "ticker_sentiment_score": "0.259551",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KMB",
                    "relevance_score": "0.02689",
                    "ticker_sentiment_score": "0.114135",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HNST",
                    "relevance_score": "0.02689",
                    "ticker_sentiment_score": "0.114135",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.02689",
                    "ticker_sentiment_score": "0.114135",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ONXXF",
                    "relevance_score": "0.02689",
                    "ticker_sentiment_score": "0.114135",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAH",
                    "relevance_score": "0.02689",
                    "ticker_sentiment_score": "0.114135",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.02689",
                    "ticker_sentiment_score": "0.259551",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "KENVUE INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses In Kenvue To Contact Him Directly To Discuss Their Options - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35716673/kenvue-investor-deadline-approaching-faruqi-faruqi-securities-litigation-partner-james-josh-wilson",
            "time_published": "20231109T223000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "If you purchased or acquired securities in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus ( collectively, the \"Registration Statement\" ) issued in connection with the Company's May 2023 initial public offering ( the \"IPO\" or \"Offering\" ) and ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                }
            ],
            "overall_sentiment_score": 0.1474,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.623692",
                    "ticker_sentiment_score": "0.025572",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.064104",
                    "ticker_sentiment_score": "0.09307",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "How To Build An Investment Portfolio For Retirement",
            "url": "https://www.forbes.com/sites/investor-hub/article/how-to-build-an-investment-portfolio-for-retirement/",
            "time_published": "20231109T214038",
            "authors": [
                "Catherine Brock"
            ],
            "summary": "When is the best time to start investing for retirement? Right now. As a rule of thumb, you need to amass about 10 times your annual salary by the time you retire. Fall short of that mark and you face a lifestyle downgrade in your senior years.",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/64c190217c4dd97edb03e3c9/0x0.jpg?format=jpg&crop=6000,3375,x0,y310,safe&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.244862,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.013892",
                    "ticker_sentiment_score": "-0.002824",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.013892",
                    "ticker_sentiment_score": "-0.002824",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.041658",
                    "ticker_sentiment_score": "0.091929",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.013892",
                    "ticker_sentiment_score": "0.196938",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.013892",
                    "ticker_sentiment_score": "0.196938",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.013892",
                    "ticker_sentiment_score": "0.196938",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here's Why You Should Retain Boston Scientific  ( BSX )  Now",
            "url": "https://www.zacks.com/stock/news/2181886/heres-why-you-should-retain-boston-scientific-bsx-now",
            "time_published": "20231109T181800",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Investors are optimistic about Boston Scientific (BSX), led by growing demand for WATCHMAN FLX devices and upbeat guidance.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999816"
                }
            ],
            "overall_sentiment_score": 0.250515,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "EW",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.090186",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNN",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.090186",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.098255",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ITGR",
                    "relevance_score": "0.195025",
                    "ticker_sentiment_score": "0.027826",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.090186",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.242406",
                    "ticker_sentiment_score": "0.218316",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.090186",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.049221",
                    "ticker_sentiment_score": "0.090186",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NARI",
                    "relevance_score": "0.195025",
                    "ticker_sentiment_score": "-0.006154",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Warren Buffett reportedly traded millions of dollars worth of stocks that Berkshire Hathaway was buying and selling",
            "url": "https://markets.businessinsider.com/news/stocks/warren-buffett-berkshire-hathaway-stocks-investors-propublica-finance-wall-street-2023-11",
            "time_published": "20231109T172900",
            "authors": [
                "Phil Rosen"
            ],
            "summary": "Warren Buffett Sold Stocks That Berkshire Was Also Trading: Report - Markets Insider ...",
            "banner_image": null,
            "source": "Business Insider",
            "category_within_source": "GoogleRSS",
            "source_domain": "markets.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.045221,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "WFC",
                    "relevance_score": "0.105604",
                    "ticker_sentiment_score": "0.116718",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.105604",
                    "ticker_sentiment_score": "0.118892",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.105604",
                    "ticker_sentiment_score": "-0.05817",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Warren Buffett reportedly traded stocks that Berkshire Hathaway was trading",
            "url": "https://www.marketwatch.com/story/warren-buffett-reportedly-traded-stocks-that-berkshire-hathaway-was-trading-9d0c8cf5",
            "time_published": "20231109T170000",
            "authors": [
                "Weston Blasi"
            ],
            "summary": "Buffett has said he 'can't be buying' the same stocks as his company Berkshire Hathaway, but a new report calls that into question ...",
            "banner_image": "https://images.mktw.net/im-666323/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.011833,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "WFC",
                    "relevance_score": "0.294093",
                    "ticker_sentiment_score": "-0.084182",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.654522",
                    "ticker_sentiment_score": "0.018401",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.294093",
                    "ticker_sentiment_score": "-0.084182",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.294093",
                    "ticker_sentiment_score": "-0.084182",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Did Warren Buffett Trade Stocks Berkshire Hathaway Owned In His Private Stock Portfolio? - JPMorgan Chase  ( NYSE:JPM ) , Johnson & Johnson  ( NYSE:JNJ ) ",
            "url": "https://www.benzinga.com/news/23/11/35704001/did-warren-buffett-trade-stocks-berkshire-hathaway-owned-in-his-private-stock-portfolio",
            "time_published": "20231109T155634",
            "authors": [
                "Chris Katje"
            ],
            "summary": "Warren Buffett is one of the most legendary stock traders of the last 50 years. A new report paints a different picture of Buffett, with potential private trades being made that could represent a conflict of interest.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Warren-Buffett.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.865346"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.064789,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "WFC",
                    "relevance_score": "0.197816",
                    "ticker_sentiment_score": "0.332464",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.197816",
                    "ticker_sentiment_score": "0.147124",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.509136",
                    "ticker_sentiment_score": "0.17885",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.149038",
                    "ticker_sentiment_score": "0.102002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.149038",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "IRS data reportedly shows Buffett traded Berkshire stocks in personal account, according to ProPublica",
            "url": "https://www.cnbc.com/2023/11/09/irs-data-reportedly-shows-buffett-traded-berkshire-stocks-in-personal-account-according-to-propublica.html",
            "time_published": "20231109T145025",
            "authors": [
                "Yun Li"
            ],
            "summary": "The nonprofit news outlet cited a leak of confidential IRS data.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107200527-1677533734938-GettyImages-1140938011_2.jpg?v=1699538858&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.040358,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "WFC",
                    "relevance_score": "0.169676",
                    "ticker_sentiment_score": "0.050728",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.331765",
                    "ticker_sentiment_score": "0.084611",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.169676",
                    "ticker_sentiment_score": "0.050728",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.169676",
                    "ticker_sentiment_score": "0.050728",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Magnificent Dow Stocks to Buy in November and 1 to Avoid Like the Plague",
            "url": "https://www.fool.com/investing/2023/11/09/2-dow-stocks-buy-in-november-1-avoid-like-plague/",
            "time_published": "20231109T102100",
            "authors": [
                "Sean Williams"
            ],
            "summary": "Two of the Dow's 30 components are historically cheap, while concerns are mounting for another time-tested business.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F753920%2Fstock-market-ticker-symbol-digital-quote-board-nyse-sp-500-nasdaq-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.714479"
                }
            ],
            "overall_sentiment_score": 0.141561,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.033421",
                    "ticker_sentiment_score": "0.120667",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TWOH",
                    "relevance_score": "0.033421",
                    "ticker_sentiment_score": "0.07885",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HCSG",
                    "relevance_score": "0.033421",
                    "ticker_sentiment_score": "0.158837",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.230704",
                    "ticker_sentiment_score": "0.184974",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.230704",
                    "ticker_sentiment_score": "0.014778",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.1331",
                    "ticker_sentiment_score": "0.156603",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "West Pharmaceutical Services Appoints Nilesh Shah as Vice President and General Manager of Emerging Markets ... - PR Newswire",
            "url": "https://www.prnewswire.com/apac/news-releases/west-pharmaceutical-services-appoints-nilesh-shah-as-vice-president-and-general-manager-of-emerging-markets-301982721.html",
            "time_published": "20231109T051707",
            "authors": [],
            "summary": "West Pharmaceutical Services Appoints Nilesh Shah as Vice President and General Manager of Emerging Markets ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.485295,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "FTV",
                    "relevance_score": "0.17715",
                    "ticker_sentiment_score": "0.158453",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WST",
                    "relevance_score": "0.424317",
                    "ticker_sentiment_score": "0.491602",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.089129",
                    "ticker_sentiment_score": "0.115932",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Voting Rights and Shares Capital of the Company",
            "url": "https://www.globenewswire.com/news-release/2023/11/08/2776737/0/en/Voting-Rights-and-Shares-Capital-of-the-Company.html",
            "time_published": "20231108T211500",
            "authors": [
                "Nanobiotix S.A."
            ],
            "summary": "In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority ( Autorité des Marchés Financiers ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/36fb7b98-27d7-46cb-b989-fa31626657b8",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.183279,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NBTX",
                    "relevance_score": "0.529185",
                    "ticker_sentiment_score": "0.212059",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.114682",
                    "ticker_sentiment_score": "0.165483",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Pharma ETFs in Focus Post Q3 Earnings",
            "url": "https://www.zacks.com/stock/news/2180987/pharma-etfs-in-focus-post-q3-earnings",
            "time_published": "20231108T161000",
            "authors": [
                "Sweta Killa"
            ],
            "summary": "Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6e/37920.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999989"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.095657,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.150357",
                    "ticker_sentiment_score": "0.047923",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SKXJF",
                    "relevance_score": "0.075516",
                    "ticker_sentiment_score": "0.072219",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSKYF",
                    "relevance_score": "0.075516",
                    "ticker_sentiment_score": "0.072219",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.113062",
                    "ticker_sentiment_score": "0.048088",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.075516",
                    "ticker_sentiment_score": "-0.043588",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.150357",
                    "ticker_sentiment_score": "0.070615",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Global Precision Medicine Market Size Demonstrates Consistent Growth with a CAGR of 11.12%, with North America Taking a Leading Role - Illumina  ( NASDAQ:ILMN ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35674541/global-precision-medicine-market-size-demonstrates-consistent-growth-with-a-cagr-of-11-12-with-nor",
            "time_published": "20231108T145000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, United States, Nov. 08, 2023 ( GLOBE NEWSWIRE ) -- Precision medicine is a new approach to treating and preventing disease that considers each individual's genetic, environmental, and lifestyle differences. Giving the proper treatment to the right patient at the right time is the goal ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.145794,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.039353",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.039353",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PACB",
                    "relevance_score": "0.039353",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ILMN",
                    "relevance_score": "0.194868",
                    "ticker_sentiment_score": "0.144939",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.039353",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QGEN",
                    "relevance_score": "0.039353",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.156461",
                    "ticker_sentiment_score": "0.115839",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Brilliant Artificial Intelligence Stocks to Buy and Hold Forever",
            "url": "https://www.fool.com/investing/2023/11/08/3-brilliant-artificial-intelligence-stocks-to-buy/",
            "time_published": "20231108T144500",
            "authors": [
                "George Budwell"
            ],
            "summary": "Healthcare stocks are widely expected to be a prime beneficiary of the AI revolution. These three names could be the best of the bunch.",
            "banner_image": "https://media.ycharts.com/charts/01d300b996544c02ee10736173aaf87e.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.394116,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GEHC",
                    "relevance_score": "0.158868",
                    "ticker_sentiment_score": "0.203089",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.210731",
                    "ticker_sentiment_score": "0.298817",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.158868",
                    "ticker_sentiment_score": "0.267419",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.158868",
                    "ticker_sentiment_score": "0.203089",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.106305",
                    "ticker_sentiment_score": "-0.006663",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Global Men's Personal Care Market Set to Reach USD 68.89 Billion by 2030, Fueled by Rising Awareness and Fashion Trends",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35672962/global-mens-personal-care-market-set-to-reach-usd-68-89-billion-by-2030-fueled-by-rising-awareness",
            "time_published": "20231108T140000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "New York, United States, Nov. 08, 2023 ( GLOBE NEWSWIRE ) -- The perception of beauty standards for men is changing. Decades-long gender stereotypes have begun to break down, and men's and women's beauty products are now being created.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.361556,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.052699",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BDRFF",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.177487",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KAOCF",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.177487",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.177487",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.177487",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UL",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.177487",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "EPC",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.177487",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LRLCF",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.177487",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "COTY",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.177487",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "RBGPF",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.177487",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Jim Cramer Asks Why The World's Largest Healthcare Products Company Has 'An Ill-Advised Strategy' - AGNC Investment  ( NASDAQ:AGNC ) , Clorox  ( NYSE:CLX ) ",
            "url": "https://www.benzinga.com/trading-ideas/long-ideas/23/11/35666275/jim-cramer-asks-why-the-worlds-largest-healthcare-products-company-has-an-ill-advised-st",
            "time_published": "20231108T133541",
            "authors": [
                "Lisa Levin"
            ],
            "summary": "On CNBC's \"Mad Money Lightning Round,\" Jim Cramer said The Clorox Company's CLX recent quarter was \"ok.\" He added, \"I think that the hack is behind them. I think Linda Rendle is doing a very good job.\" AGNC Investment Corp. AGNC has \"been a dog so long,\" Cramer said, \"It's just been a value trap.\"",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/08/jim_cramer_shutter4.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.012186,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CSCO",
                    "relevance_score": "0.539306",
                    "ticker_sentiment_score": "0.061521",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AGNC",
                    "relevance_score": "0.539306",
                    "ticker_sentiment_score": "0.051247",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VTR",
                    "relevance_score": "0.539306",
                    "ticker_sentiment_score": "-0.071567",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLX",
                    "relevance_score": "0.539306",
                    "ticker_sentiment_score": "-0.145642",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.539306",
                    "ticker_sentiment_score": "-0.064939",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Grab these 2 funds with rich 11%-12% yields while you can",
            "url": "https://www.marketwatch.com/story/grab-these-2-funds-with-rich-11-12-yields-while-you-can-f2856fb2",
            "time_published": "20231108T121800",
            "authors": [
                "Michael Brush"
            ],
            "summary": "If you invest for income, consider taking advantage of these unusual opportunities.",
            "banner_image": "https://images.mktw.net/im-879591/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.166559,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.232625",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HESG",
                    "relevance_score": "0.045054",
                    "ticker_sentiment_score": "0.208956",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.166414",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.166414",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MORN",
                    "relevance_score": "0.045054",
                    "ticker_sentiment_score": "0.060686",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.166414",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.089965",
                    "ticker_sentiment_score": "0.219686",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "NANOBIOTIX Announces Closing of Global Offering",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35657744/nanobiotix-announces-closing-of-global-offering",
            "time_published": "20231107T210100",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "PARIS and CAMBRIDGE, Mass., Nov. 07, 2023 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO - NASDAQ: NBTX - \"Nanobiotix\" or the \"Company\" ) , a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announces the ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999174"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.122071,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NBTX",
                    "relevance_score": "0.197951",
                    "ticker_sentiment_score": "0.044418",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STT",
                    "relevance_score": "0.022222",
                    "ticker_sentiment_score": "0.056509",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.022222",
                    "ticker_sentiment_score": "0.046698",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:NANO",
                    "relevance_score": "0.044427",
                    "ticker_sentiment_score": "0.035549",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Inside the Dividend Monarchs ETF  ( KNGS ) ",
            "url": "https://www.zacks.com/stock/news/2180335/inside-the-dividend-monarchs-etf-kngs",
            "time_published": "20231107T190000",
            "authors": [
                "Sanghamitra Saha"
            ],
            "summary": "The newly-launched KNGS ETF holds 30+ stocks. These stocks have been in a position to consistently raise their dividends over the last 50 years.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default77.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999939"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.212486,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PEP",
                    "relevance_score": "0.073321",
                    "ticker_sentiment_score": "-0.005071",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.073321",
                    "ticker_sentiment_score": "-0.005071",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.073321",
                    "ticker_sentiment_score": "-0.005071",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.073321",
                    "ticker_sentiment_score": "-0.005071",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Q1 2023/24 - Lower revenue in a challenging market",
            "url": "https://www.globenewswire.com/news-release/2023/11/07/2775449/0/en/Q1-2023-24-Lower-revenue-in-a-challenging-market.html",
            "time_published": "20231107T190000",
            "authors": [
                "Chemometec A/S"
            ],
            "summary": "ANNOUNCEMENT NO. ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/dda6d08e-1d43-433e-bc7b-b1e84b4963be",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.576289"
                }
            ],
            "overall_sentiment_score": -0.033238,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.029951",
                    "ticker_sentiment_score": "0.037699",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.029951",
                    "ticker_sentiment_score": "0.037699",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.029951",
                    "ticker_sentiment_score": "0.037699",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Genmab Announces Financial Results for the First Nine Months of 2023",
            "url": "https://www.globenewswire.com/news-release/2023/11/07/2775338/0/en/Genmab-Announces-Financial-Results-for-the-First-Nine-Months-of-2023.html",
            "time_published": "20231107T160100",
            "authors": [
                "Genmab A/S"
            ],
            "summary": "November 7, 2023 Copenhagen, Denmark. Interim Report for the First Nine Months Ended September ...",
            "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.129352,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NVS",
                    "relevance_score": "0.036091",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.143629",
                    "ticker_sentiment_score": "0.083262",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SGEN",
                    "relevance_score": "0.107978",
                    "ticker_sentiment_score": "0.065655",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GMAB",
                    "relevance_score": "0.412861",
                    "ticker_sentiment_score": "0.117511",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BNTX",
                    "relevance_score": "0.072108",
                    "ticker_sentiment_score": "0.073576",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.036091",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Johnson & Johnson to submit application to start trials for surgical robot",
            "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-submit-application-start-trials-its-robotic-surgical-system-2023-11-07/",
            "time_published": "20231107T131200",
            "authors": [
                "Reuters"
            ],
            "summary": "Johnson & Johnson to submit application to start trials for its robotic surgical system ...",
            "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/4L7SJNLFZJJ65BIEBCLWLVUH2M.jpg",
            "source": "Reuters",
            "category_within_source": "Business",
            "source_domain": "www.reuters.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.126574,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MDT",
                    "relevance_score": "0.282234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.282234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.282234",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Magnificent Dividend Stocks Trading Near 52-Week Lows to Buy Now and Hold at Least a Decade",
            "url": "https://www.fool.com/investing/2023/11/07/2-magnificent-dividend-stocks-trading-near-52-week/",
            "time_published": "20231107T103700",
            "authors": [
                "Cory Renauer"
            ],
            "summary": "Taking advantage of the discounted prices these stocks have been trading at could do wonders for your passive income stream.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F753925%2Fcouple-looking-at-stocks-on-tablet-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.714479"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.200775,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.055621",
                    "ticker_sentiment_score": "0.204955",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MO",
                    "relevance_score": "0.514619",
                    "ticker_sentiment_score": "0.20114",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "0.223045",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Anti-Infective Drugs Market to Hit USD 177.9 billion by 2031 | Transparency Market Research Inc.",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35637643/anti-infective-drugs-market-to-hit-usd-177-9-billion-by-2031-transparency-market-research-inc",
            "time_published": "20231107T103000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Wilmington, Delaware, United States, Nov. 07, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global anti-infective drugs market is projected to flourish at a CAGR of 4.0% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 117.9 billion is anticipated for ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                }
            ],
            "overall_sentiment_score": 0.195618,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "-0.109878",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALPMF",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "-0.109878",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "-0.109878",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "-0.109878",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HCSG",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.212463",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "-0.109878",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TAK",
                    "relevance_score": "0.043658",
                    "ticker_sentiment_score": "-0.109878",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Monster Stocks to Buy Without Any Hesitation",
            "url": "https://www.fool.com/investing/2023/11/07/2-monster-stocks-to-buy-without-any-hesitation/",
            "time_published": "20231107T100500",
            "authors": [
                "Josh Kohn-Lindquist"
            ],
            "summary": "Down 33% and 44%, these two stocks look too good to pass up today.",
            "banner_image": "https://media.ycharts.com/charts/fd056e541104c424277123a2aae7f156.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.658903"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                }
            ],
            "overall_sentiment_score": 0.082347,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.429752",
                    "ticker_sentiment_score": "0.131906",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RMD",
                    "relevance_score": "0.240149",
                    "ticker_sentiment_score": "0.123234",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.034831",
                    "ticker_sentiment_score": "-0.193184",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.034831",
                    "ticker_sentiment_score": "-0.076883",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Mobile health solutions market to grow at a USD 256.69 billion from 2022 to 2027 | Abbott Laboratories, AirStrip ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/mobile-health-solutions-market-to-grow-at-a-usd-256-69-billion-from-2022-to-2027--abbott-laboratories-airstrip-technologies-inc-apple-inc-and-more-among-the-key-companies-in-the-market---technavio-301978707.html",
            "time_published": "20231107T011500",
            "authors": [],
            "summary": "Mobile health solutions market to grow at a USD 256.69 billion from 2022 to 2027 | Abbott Laboratories, AirStrip ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.324869,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.143994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CSCO",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.143994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.143994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.143994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MASI",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.275034",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ORCL",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.143994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NOK",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.143994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.143994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OMRNF",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.143994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.143994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QCOM",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.143994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDRX",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.143994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.143994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.143994",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman - and Martin Shkreli",
            "url": "https://www.marketwatch.com/story/the-doctor-lowering-drug-prices-for-1-million-patients-with-help-from-mark-cuban-sam-altman-and-martin-shkreli-5e72d77a",
            "time_published": "20231106T203200",
            "authors": [
                "Eleanor Laise"
            ],
            "summary": "Kristopher Koeller relies on two daily medications to keep his blood pressure under control. They're both generics that have been on the market for decades-the kind of drugs that should be cheap.",
            "banner_image": "https://images.mktw.net/im-871045?width=700&height=393",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.066744,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CVS",
                    "relevance_score": "0.055848",
                    "ticker_sentiment_score": "-0.013012",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.027941",
                    "ticker_sentiment_score": "0.088489",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.027941",
                    "ticker_sentiment_score": "0.024774",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.027941",
                    "ticker_sentiment_score": "0.088489",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CHRS",
                    "relevance_score": "0.027941",
                    "ticker_sentiment_score": "0.007658",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.041901",
                    "ticker_sentiment_score": "0.007958",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.027941",
                    "ticker_sentiment_score": "0.007658",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.027941",
                    "ticker_sentiment_score": "0.007658",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.027941",
                    "ticker_sentiment_score": "0.024774",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.027941",
                    "ticker_sentiment_score": "-0.042172",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly chief scientific officer 'extremely optimistic' that major new Alzheimer's breakthrough is coming",
            "url": "https://www.marketwatch.com/story/eli-lilly-chief-scientific-officer-extremely-optimistic-that-major-new-alzheimers-breakthrough-is-coming-79003fcc",
            "time_published": "20231106T160500",
            "authors": [
                "Eleanor Laise"
            ],
            "summary": "Dr. Daniel Skovronsky believes a big leap in Alzheimer's disease treatment may be just around the corner-and that an overlooked class of medicines could become the GLP-1 drugs of the future. If he's right, Eli Lilly & Co.'s LLY, remarkable winning streak won't fizzle any time soon.",
            "banner_image": "https://images.mktw.net/im-857606/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                }
            ],
            "overall_sentiment_score": 0.125979,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.365524",
                    "ticker_sentiment_score": "0.148178",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.075754",
                    "ticker_sentiment_score": "0.013501",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.113418",
                    "ticker_sentiment_score": "0.152012",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.075754",
                    "ticker_sentiment_score": "0.013501",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.075754",
                    "ticker_sentiment_score": "0.154848",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner, Accelerating Long-Term Growth Strategies for Both Organizations",
            "url": "https://www.prnewswire.com/news-releases/kohler-co-to-establish-energy-division-as-independent-business-with-platinum-equity-as-majority-investment-partner-accelerating-long-term-growth-strategies-for-both-organizations-301978609.html",
            "time_published": "20231106T160000",
            "authors": [
                "Kohler Co."
            ],
            "summary": "Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/619434/Kohler_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.472755,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "IR",
                    "relevance_score": "0.035397",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EMR",
                    "relevance_score": "0.035397",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.035397",
                    "ticker_sentiment_score": "0.020275",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.035397",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PSIX",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.268035",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner, Accelerating Long-Term Growth Strategies for Both Organizations",
            "url": "https://www.prnewswire.com/in/news-releases/kohler-co-to-establish-energy-division-as-independent-business-with-platinum-equity-as-majority-investment-partner-accelerating-long-term-growth-strategies-for-both-organizations-301978615.html",
            "time_published": "20231106T160000",
            "authors": [
                "Kohler Co."
            ],
            "summary": "Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/619434/Kohler_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.472755,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "IR",
                    "relevance_score": "0.035397",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EMR",
                    "relevance_score": "0.035397",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.035397",
                    "ticker_sentiment_score": "0.020275",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.035397",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PSIX",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.268035",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner, Accelerating Long-Term Growth Strategies for Both Organizations",
            "url": "https://www.newswire.ca/news-releases/kohler-co-to-establish-energy-division-as-independent-business-with-platinum-equity-as-majority-investment-partner-accelerating-long-term-growth-strategies-for-both-organizations-871976866.html",
            "time_published": "20231106T160000",
            "authors": [
                "Kohler Co."
            ],
            "summary": "Kohler Co. to Establish Energy Division as Independent Business with Platinum Equity as Majority Investment Partner ... Canada ...",
            "banner_image": "https://mma.prnewswire.com/media/619434/Kohler_Logo.jpg?p=facebook",
            "source": "Canada Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.newswire.ca",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.472755,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "IR",
                    "relevance_score": "0.035397",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EMR",
                    "relevance_score": "0.035397",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.035397",
                    "ticker_sentiment_score": "0.020275",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.035397",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PSIX",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.268035",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Mind-altering ketamine becomes new pain treatment, despite little research or regulation",
            "url": "https://apnews.com/article/ketamine-pain-drugs-psychedelic-fda-2c67eeac1932962a7b0affc07d24c09a",
            "time_published": "20231106T135700",
            "authors": [
                "MATTHEW PERRONE"
            ],
            "summary": "WASHINGTON ( AP ) - As U.S. doctors scale back their use of , a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a .",
            "banner_image": "https://dims.apnews.com/dims4/default/4d1405a/2147483647/strip/true/crop/5138x3422+0+1/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2Fcb%2Fcc%2F05d9f9c9a82aa131c2ce9b7f669f%2F862a7fd642e64538b8d642dc596641cc",
            "source": "Associated Press",
            "category_within_source": "Markets",
            "source_domain": "apnews.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": -0.190668,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "HHH",
                    "relevance_score": "0.028695",
                    "ticker_sentiment_score": "0.156844",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.028695",
                    "ticker_sentiment_score": "-0.163383",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Anavex Life Sciences Appoints Senior VP of Regulatory Affairs",
            "url": "https://www.globenewswire.com/news-release/2023/11/06/2774022/29248/en/Anavex-Life-Sciences-Appoints-Senior-VP-of-Regulatory-Affairs.html",
            "time_published": "20231106T130000",
            "authors": [
                "Anavex Life Sciences Corp."
            ],
            "summary": "NEW YORK, Nov. 06, 2023 ( GLOBE NEWSWIRE ) -- Anavex Life Sciences Corp. ( \"Anavex\" or the \"Company\" ) ( Nasdaq: AVXL ) , a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders, including ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/1b0f858f-4f7f-4f50-b691-a25307283fb5",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.151385,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.04583",
                    "ticker_sentiment_score": "0.048786",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVXL",
                    "relevance_score": "0.22616",
                    "ticker_sentiment_score": "-0.001786",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.04583",
                    "ticker_sentiment_score": "0.101487",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35611321/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc-kvue",
            "time_published": "20231105T213127",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "NEW YORK, Nov. 05, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( \"Kenvue\" or the \"Company\" ) KVUE. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                }
            ],
            "overall_sentiment_score": 0.021762,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.691995",
                    "ticker_sentiment_score": "0.011422",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.021477",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest - CVS Health  ( NYSE:CVS ) , SPDR Select Sector Fund - Health Care  ( ARCA:XLV ) , Johnson & Johnson  ( NYSE:JNJ ) , Walgreens Boots Alliance  ( NASDAQ:WBA ) ",
            "url": "https://www.benzinga.com/news/23/11/35610842/pharmacy-workers-strike-at-cvs-and-walgreens-echoing-wider-pharma-sector-unrest",
            "time_published": "20231105T204848",
            "authors": [
                "Bibhu Pattnaik"
            ],
            "summary": "In a recent surge of labor unrest, pharmacy employees from CVS Health Corporation CVS and Walgreens Boots Alliance, Inc. WBA raised their voices by calling out sick or walking out entirely last week.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/05/shutterstock_1049642744.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.08705,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CVS",
                    "relevance_score": "0.343755",
                    "ticker_sentiment_score": "0.16233",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.14131",
                    "ticker_sentiment_score": "0.067842",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RADCQ",
                    "relevance_score": "0.070935",
                    "ticker_sentiment_score": "-0.096496",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.14131",
                    "ticker_sentiment_score": "-0.093063",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.14131",
                    "ticker_sentiment_score": "-0.207786",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NYT",
                    "relevance_score": "0.14131",
                    "ticker_sentiment_score": "-0.206552",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.14131",
                    "ticker_sentiment_score": "-0.093063",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "KVUE Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Kenvue Inc.  ( KVUE )  Investors of Securities Fraud Class Action Lawsuit - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35606416/kvue-class-action-reminder-kessler-topaz-meltzer-check-llp-reminds-kenvue-inc-kvue-investors-of-se",
            "time_published": "20231104T144600",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "RADNOR, Pa., Nov. 04, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Kenvue Inc. ( \"Kenvue\" ) KVUE. ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": 0.096899,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.526003",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.129961",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "KENVUE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses In Kenvue To Contact Him Directly To Discuss Their Options - Kenvue  ( NYSE:KVUE ) ",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35605845/kenvue-shareholder-action-reminder-faruqi-faruqi-securities-litigation-partner-james-josh-wilson-e",
            "time_published": "20231104T120000",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "If you purchased or acquired securities in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus ( collectively, the \"Registration Statement\" ) issued in connection with the Company's May 2023 initial public offering ( the \"IPO\" or \"Offering\" ) and ...",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                }
            ],
            "overall_sentiment_score": 0.1474,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.623692",
                    "ticker_sentiment_score": "0.025572",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.064104",
                    "ticker_sentiment_score": "0.09307",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever",
            "url": "https://www.fool.com/investing/2023/11/04/want-passive-income-top-dividend-stocks-to-buy/",
            "time_published": "20231104T093000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "Dividend stocks can cushion your portfolio in times of market trouble.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F753700%2Fgettyimages-1319763362.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.947132"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.366922,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.367606",
                    "ticker_sentiment_score": "0.354643",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.054483",
                    "ticker_sentiment_score": "0.047997",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.108712",
                    "ticker_sentiment_score": "0.104043",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "KENVUE SHAREHOLDER ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/kenvue-shareholder-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-kenvue-to-contact-him-directly-to-discuss-their-options-301976714.html",
            "time_published": "20231104T004500",
            "authors": [],
            "summary": "KENVUE SHAREHOLDER ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                }
            ],
            "overall_sentiment_score": 0.150018,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.600121",
                    "ticker_sentiment_score": "0.021496",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.061003",
                    "ticker_sentiment_score": "0.093005",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Weekly Roundup",
            "url": "https://aap.thestreet.com/story/16137219/1/weekly-roundup.html",
            "time_published": "20231103T222900",
            "authors": [],
            "summary": "All four major market indexes climbed higher in the first days of November, putting each except for the Russell 2000 in positive territory quarter-to date. A less-hawkish-than-expected Fed, retreating Treasury yields and slower job growth spurred the buying.",
            "banner_image": "https://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/391cf3d8-7a8d-11ee-b0ee-d18e297040ba.png",
            "source": "The Street",
            "category_within_source": "GoogleRSS",
            "source_domain": "aap.thestreet.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.99489"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.142857"
                }
            ],
            "overall_sentiment_score": 0.189331,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AMAT",
                    "relevance_score": "0.007738",
                    "ticker_sentiment_score": "0.032106",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CELH",
                    "relevance_score": "0.007738",
                    "ticker_sentiment_score": "0.098697",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVS",
                    "relevance_score": "0.003869",
                    "ticker_sentiment_score": "-0.017189",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DE",
                    "relevance_score": "0.02321",
                    "ticker_sentiment_score": "0.084109",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.007738",
                    "ticker_sentiment_score": "0.098697",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.02321",
                    "ticker_sentiment_score": "0.112497",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDNDF",
                    "relevance_score": "0.034809",
                    "ticker_sentiment_score": "0.096219",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TRIN",
                    "relevance_score": "0.015474",
                    "ticker_sentiment_score": "0.072102",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TTD",
                    "relevance_score": "0.007738",
                    "ticker_sentiment_score": "0.025532",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.003869",
                    "ticker_sentiment_score": "0.093507",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.007738",
                    "ticker_sentiment_score": "0.154498",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AXON",
                    "relevance_score": "0.011606",
                    "ticker_sentiment_score": "0.110566",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "YERBF",
                    "relevance_score": "0.007738",
                    "ticker_sentiment_score": "0.098697",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "URI",
                    "relevance_score": "0.02321",
                    "ticker_sentiment_score": "0.045618",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.02321",
                    "ticker_sentiment_score": "0.092246",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.003869",
                    "ticker_sentiment_score": "0.070906",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COST",
                    "relevance_score": "0.027077",
                    "ticker_sentiment_score": "0.12651",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STT",
                    "relevance_score": "0.003869",
                    "ticker_sentiment_score": "-0.019235",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MA",
                    "relevance_score": "0.015474",
                    "ticker_sentiment_score": "0.086543",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.003869",
                    "ticker_sentiment_score": "0.096158",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GFS",
                    "relevance_score": "0.007738",
                    "ticker_sentiment_score": "0.025532",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QCOM",
                    "relevance_score": "0.042537",
                    "ticker_sentiment_score": "0.109398",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OLED",
                    "relevance_score": "0.015474",
                    "ticker_sentiment_score": "-0.020098",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UTZ",
                    "relevance_score": "0.015474",
                    "ticker_sentiment_score": "0.076312",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CMG",
                    "relevance_score": "0.030943",
                    "ticker_sentiment_score": "0.097072",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.015474",
                    "ticker_sentiment_score": "0.10054",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HUM",
                    "relevance_score": "0.003869",
                    "ticker_sentiment_score": "-0.017189",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSI",
                    "relevance_score": "0.007738",
                    "ticker_sentiment_score": "0.198468",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.030943",
                    "ticker_sentiment_score": "0.099277",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "USEG",
                    "relevance_score": "0.003869",
                    "ticker_sentiment_score": "0.039346",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMT",
                    "relevance_score": "0.007738",
                    "ticker_sentiment_score": "0.120363",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ICNB",
                    "relevance_score": "0.003869",
                    "ticker_sentiment_score": "0.178317",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VMC",
                    "relevance_score": "0.011606",
                    "ticker_sentiment_score": "0.02438",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LMT",
                    "relevance_score": "0.02321",
                    "ticker_sentiment_score": "0.101726",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNHI",
                    "relevance_score": "0.015474",
                    "ticker_sentiment_score": "0.046086",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FTNT",
                    "relevance_score": "0.011606",
                    "ticker_sentiment_score": "0.023035",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLESY",
                    "relevance_score": "0.003869",
                    "ticker_sentiment_score": "0.069533",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IPAR",
                    "relevance_score": "0.007738",
                    "ticker_sentiment_score": "0.025532",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.019342",
                    "ticker_sentiment_score": "0.090796",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.042537",
                    "ticker_sentiment_score": "0.102618",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYNA",
                    "relevance_score": "0.007738",
                    "ticker_sentiment_score": "0.025532",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.003869",
                    "ticker_sentiment_score": "0.10621",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kenvue Inc. - KVUE",
            "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-kenvue-inc---kvue-301977470.html",
            "time_published": "20231103T203600",
            "authors": [
                "Pomerantz LLP"
            ],
            "summary": "NEW YORK, Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Kenvue Inc. ( \"Kenvue\" or the \"Company\" ) ( NYSE: KVUE ) . Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.",
            "banner_image": "https://mma.prnewswire.com/media/1486339/Pomerantz_Logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.650727"
                }
            ],
            "overall_sentiment_score": 0.053268,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KVUE",
                    "relevance_score": "0.725935",
                    "ticker_sentiment_score": "0.070022",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.124164",
                    "ticker_sentiment_score": "0.023342",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Medela Announces Transition of Wound Care Business, Creating a New Company Dedicated to Wound Therapy Solutions",
            "url": "https://www.benzinga.com/pressreleases/23/11/g35597861/medela-announces-transition-of-wound-care-business-creating-a-new-company-dedicated-to-wound-thera",
            "time_published": "20231103T174242",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "Baar, Switzerland, Nov. 03, 2023 ( GLOBE NEWSWIRE ) -- Medela, a global healthcare company known for being the most trusted breastfeeding brand in North America*, announced it will transition its wound care business into a separate global company.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "Mergers",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.301002,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.055492",
                    "ticker_sentiment_score": "0.140718",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Council Post: What Startups Can Learn From Titans About Treasury Management",
            "url": "https://www.forbes.com/sites/forbesbusinesscouncil/2023/11/03/what-startups-can-learn-from-titans-about-treasury-management/",
            "time_published": "20231103T143000",
            "authors": [
                "Will Fan"
            ],
            "summary": "What Startups Can Learn From Titans About Treasury Management Forbes ...",
            "banner_image": "https://imageio.forbes.com/specials-images/imageserve/646f6244f3faa9c0f6569957/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "source": "Forbes",
            "category_within_source": "n/a",
            "source_domain": "www.forbes.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.33964,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.104835",
                    "ticker_sentiment_score": "0.314809",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.035035",
                    "ticker_sentiment_score": "0.067637",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "This Stock Just Dropped By 15%: Is It a Buy?",
            "url": "https://www.fool.com/investing/2023/11/03/this-stock-just-dropped-by-15-is-it-a-buy/",
            "time_published": "20231103T140700",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "Now could be a great opportunity to buy low.",
            "banner_image": "https://media.ycharts.com/charts/f17aae7f0e5b860659a29816cf8131bc.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.714479"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                }
            ],
            "overall_sentiment_score": 0.159727,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "PFE",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "0.047",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.061315",
                    "ticker_sentiment_score": "0.047",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.461699",
                    "ticker_sentiment_score": "0.192137",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Johnson & Johnson  ( JNJ )  is Attracting Investor Attention: Here is What You Should Know",
            "url": "https://www.zacks.com/stock/news/2177963/johnson-johnson-jnj-is-attracting-investor-attention-here-is-what-you-should-know",
            "time_published": "20231103T130010",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default355.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.503496"
                }
            ],
            "overall_sentiment_score": 0.237374,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.478494",
                    "ticker_sentiment_score": "0.159977",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "3 Top-Ranked PIMCO Mutual Funds for 2023 & Beyond",
            "url": "https://www.zacks.com/stock/news/2177867/3-top-ranked-pimco-mutual-funds-for-2023-beyond",
            "time_published": "20231103T105300",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Invest in PIMCO mutual funds like PMJPX, PKAAX and PQIPX that have given positive returns amid uncertain market conditions and are expected to perform well in the future.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f1/51384.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999922"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.272157,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.050941",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DDS",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.050941",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVGO",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.05394",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CSCO",
                    "relevance_score": "0.113866",
                    "ticker_sentiment_score": "0.058594",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.05394",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANF",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.050941",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HCC",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.050941",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.057079",
                    "ticker_sentiment_score": "0.050941",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Healthcare Stocks to Buy Hand Over Fist in November",
            "url": "https://www.fool.com/investing/2023/11/03/3-health-stocks-to-buy-hand-over-fist-in-november/",
            "time_published": "20231103T090000",
            "authors": [
                "Adria Cimino"
            ],
            "summary": "Get these stocks while they're cheap.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F753459%2Fgettyimages-1027653456.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.9996"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.302997,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MDT",
                    "relevance_score": "0.414559",
                    "ticker_sentiment_score": "0.482054",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.162073",
                    "ticker_sentiment_score": "0.183261",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Wound Care Market to grow by USD 6.83 billion from 2022 to 2027|3M Co., Advancis Medical, Avery Dennison Corp ... - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/wound-care-market-to-grow-by-usd-6-83-billion-from-2022-to-20273m-co-advancis-medical-avery-dennison-corp-axio-biosolutions-pvt-ltd-and-more-among-the-key-companies-in-the-market---technavio-301976551.html",
            "time_published": "20231103T073500",
            "authors": [],
            "summary": "Wound Care Market to grow by USD 6.83 billion from 2022 to 2027|3M Co., Advancis Medical, Avery Dennison Corp ... PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.041186,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SNN",
                    "relevance_score": "0.049939",
                    "ticker_sentiment_score": "0.082775",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVY",
                    "relevance_score": "0.049939",
                    "ticker_sentiment_score": "0.082775",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.049939",
                    "ticker_sentiment_score": "0.082775",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.049939",
                    "ticker_sentiment_score": "0.082775",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAH",
                    "relevance_score": "0.049939",
                    "ticker_sentiment_score": "0.082775",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZLGF",
                    "relevance_score": "0.049939",
                    "ticker_sentiment_score": "0.082775",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDT",
                    "relevance_score": "0.049939",
                    "ticker_sentiment_score": "0.082775",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MMM",
                    "relevance_score": "0.049939",
                    "ticker_sentiment_score": "0.082775",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLPBY",
                    "relevance_score": "0.049939",
                    "ticker_sentiment_score": "0.082775",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORGO",
                    "relevance_score": "0.049939",
                    "ticker_sentiment_score": "0.082775",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CNVVF",
                    "relevance_score": "0.049939",
                    "ticker_sentiment_score": "0.082775",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        }
    ]
}